☰

cached image

Roel Prins - Publications

Affiliations: 
Eidgenössische Technische Hochschule Zürich, Zürich, ZH, Switzerland 
Area:
physical chemistry
Website:
http://ch.linkedin.com/pub/roel-prins/25/95b/1ba
Tree Info Similar researchers PubMed Report error

72/351 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Zhou X, Li X, Prins R, Lv J, Wang A, Sheng Q. Hydrodesulfurization of dibenzothiophene and its hydrogenated intermediates over bulk CoP and Co2P catalysts with stoichiometric P/Co ratios Journal of Catalysis. DOI: 10.1016/J.Jcat.2020.08.030  0.429
2017 Li X, Tian S, Wang A, Prins R, Li C, Chen Y. XPS study of a bulk WP hydrodesulfurization catalyst Journal of Catalysis. 352: 557-561. DOI: 10.1016/J.Jcat.2017.06.023  0.406
2017 Liu D, Wang A, Liu C, Prins R. Ni2P/Al2O3 hydrodesulfurization catalysts prepared by separating the nickel compound and hypophosphite Catalysis Today. 292: 133-142. DOI: 10.1016/J.Cattod.2016.09.019  0.394
2016 Tian S, Li X, Wang A, Prins R, Chen Y, Hu Y. Facile Preparation of Ni2 P with a Sulfur-Containing Surface Layer by Low-Temperature Reduction of Ni2 P2 S6. Angewandte Chemie (International Ed. in English). PMID 26891348 DOI: 10.1002/Anie.201510599  0.36
2016 Liu D, Wang A, Liu C, Prins R. Bulk and Al2O3-supported Ni2P HDS catalysts prepared by separating the nickel and hypophosphite sources Catalysis Communications. 77: 13-17. DOI: 10.1016/J.Catcom.2016.01.008  0.399
2015 Yang L, Li X, Wang A, Prins R, Chen Y, Duan X. Hydrodesulfurization of dibenzothiophene, 4,6-dimethyldibenzothiophene, and their hydrogenated intermediates over bulk tungsten phosphide Journal of Catalysis. 330: 330-343. DOI: 10.1016/J.Jcat.2015.07.019  0.362
2014 Zhao Z, Wu H, Duan A, Li T, Prins R, Zhou X. Synthesis of NiMo hydrodesulfurization catalyst supported on a composite of nano-sized ZSM-5 zeolite enwrapped with mesoporous KIT-6 material and its high isomerization selectivity Journal of Catalysis. 317: 303-317. DOI: 10.1016/J.Jcat.2014.07.002  0.455
2014 Yang L, Li X, Wang A, Prins R, Wang Y, Chen Y, Duan X. Hydrodesulfurization of 4,6-dimethyldibenzothiophene and its hydrogenated intermediates over bulk Ni2P Journal of Catalysis. 317: 144-152. DOI: 10.1016/J.Jcat.2014.06.020  0.402
2012 Bai J, Li X, Wang A, Prins R, Wang Y. Hydrodesulfurization of dibenzothiophene and its hydrogenated intermediates over bulk MoP Journal of Catalysis. 287: 161-169. DOI: 10.1016/J.Jcat.2011.12.018  0.412
2012 Prins R, Bussell ME. Metal phosphides: Preparation, characterization and catalytic reactivity Catalysis Letters. 142: 1413-1436. DOI: 10.1007/S10562-012-0929-7  0.375
2011 Li X, Bai J, Wang A, Prins R, Wang Y. Hydrodesulfurization of Dibenzothiophene and its Hydrogenated Intermediates over Bulk Ni2P Topics in Catalysis. 54: 290-298. DOI: 10.1007/S11244-011-9663-4  0.402
2011 Xu X, Li X, Wang A, Sun Y, Schweizer WB, Prins R. Synthesis of 4,6-dimethyldibenzothiophene and 1,2,3,4-tetrahydro-4,6- dimethyldibenzothiophene via Tilak annulation Helvetica Chimica Acta. 94: 1754-1763. DOI: 10.1002/Hlca.201100191  0.336
2010 Sun Y, Wang H, Prins R. Hydrodesulfurization with classic Co-MoS2 and Ni-MoS2/γ-Al2O3 and new Pt-Pd on mesoporous zeolite catalysts Catalysis Today. 150: 213-217. DOI: 10.1016/J.Cattod.2009.07.093  0.456
2009 Liang C, Zhao A, Zhang X, Ma Z, Prins R. CoSi particles on silica support as a highly active and selective catalyst for naphthalene hydrogenation. Chemical Communications (Cambridge, England). 2047-9. PMID 19333486 DOI: 10.1039/B820519A  0.403
2009 Sun Y, Prins R. Mechanistic studies and kinetics of the hydrodesulfurization of dibenzothiophene on Co-MoS2/γ-Al2O3 Journal of Catalysis. 267: 193-201. DOI: 10.1016/J.Jcat.2009.08.013  0.363
2009 Wang H, Prins R. Hydrodesulfurization of dibenzothiophene, 4,6-dimethyldibenzothiophene, and their hydrogenated intermediates over Ni-MoS2/γ-Al2O3 Journal of Catalysis. 264: 31-43. DOI: 10.1016/J.Jcat.2009.03.011  0.351
2008 Sun Y, Prins R. Hydrodesulfurization of 4,6-dimethyldibenzothiophene over noble metals supported on mesoporous zeolites. Angewandte Chemie (International Ed. in English). 47: 8478-81. PMID 18825769 DOI: 10.1002/Anie.200802540  0.301
2008 Wang A, Qin M, Guan J, Wang L, Guo H, Li X, Wang Y, Prins R, Hu Y. The synthesis of metal phosphides: reduction of oxide precursors in a hydrogen plasma. Angewandte Chemie (International Ed. in English). 47: 6052-4. PMID 18604795 DOI: 10.1002/Anie.200801559  0.312
2008 Sun Y, Wang H, Prins R. Synthesis of 4,6-dimethyl-tetrahydro- and hexahydro-dibenzothiophene Tetrahedron Letters. 49: 2063-2065. DOI: 10.1016/J.Tetlet.2008.02.003  0.367
2008 Wang H, Prins R. Hydrodesulfurization of dibenzothiophene and its hydrogenated intermediates over sulfided Mo/γ-Al2O3 Journal of Catalysis. 258: 153-164. DOI: 10.1016/J.Jcat.2008.06.005  0.367
2008 Guo H, Sun Y, Prins R. Hydrodesulfurization of 4,6-dimethyldibenzothiophene over Pt supported on γ-Al2O3, SBA-15, and HZSM-5 Catalysis Today. 130: 249-253. DOI: 10.1016/J.Cattod.2007.07.007  0.401
2008 Roy PK, Prins R, Pirngruber GD. The effect of pretreatment on the reactivity of Fe-ZSM-5 catalysts for N2O decomposition: Dehydroxylation vs. steaming Applied Catalysis B: Environmental. 80: 226-236. DOI: 10.1016/J.Apcatb.2007.10.015  0.404
2008 Wang H, Prins R. HDS of benzothiophene and dihydrobenzothiophene over sulfided Mo/γ-Al2O3 Applied Catalysis a: General. 350: 191-196. DOI: 10.1016/J.Apcata.2008.08.010  0.396
2008 Sun Y, Prins R. Friedel-Crafts alkylations over hierarchical zeolite catalysts Applied Catalysis a: General. 336: 11-16. DOI: 10.1016/j.apcata.2007.08.015  0.326
2007 Bus E, Prins R, van Bokhoven JA. Time-resolved in situ XAS study of the preparation of supported gold clusters. Physical Chemistry Chemical Physics : Pccp. 9: 3312-20. PMID 17579741 DOI: 10.1039/B702747H  0.322
2007 Niquille-Röthlisberger A, Prins R. Influence of nitrogen-containing compounds on the hydrodesulfurization of 4,6-dimethyldibenzothiophene over Pt, Pd, and Pt-Pd on amorphous silica-alumina catalysts Industrial and Engineering Chemistry Research. 46: 4124-4133. DOI: 10.1021/Ie0610849  0.358
2007 Wang H, Liang C, Prins R. Hydrodenitrogenation of 2-methylpyridine and its intermediates 2-methylpiperidine and tetrahydro-methylpyridine over sulfided NiMo/γ-Al2O3 Journal of Catalysis. 251: 295-306. DOI: 10.1016/J.Jcat.2007.08.005  0.372
2007 Li X, Wang A, Egorova M, Prins R. Kinetics of the HDS of 4,6-dimethyldibenzothiophene and its hydrogenated intermediates over sulfided Mo and NiMo on γ-Al2O3 Journal of Catalysis. 250: 283-293. DOI: 10.1016/J.Jcat.2007.06.005  0.405
2007 Pirngruber GD, Roy PK, Prins R. The role of autoreduction and of oxygen mobility in N2O decomposition over Fe-ZSM-5 Journal of Catalysis. 246: 147-157. DOI: 10.1016/J.Jcat.2006.11.030  0.415
2007 Niquille-Röthlisberger A, Prins R. Hydrodesulfurization of 4,6-dimethyldibenzothiophene over Pt, Pd, and Pt-Pd catalysts supported on amorphous silica-alumina Catalysis Today. 123: 198-207. DOI: 10.1016/J.Cattod.2007.01.053  0.418
2007 Bus E, Prins R, van Bokhoven JA. Origin of the cluster-size effect in the hydrogenation of cinnamaldehyde over supported Au catalysts Catalysis Communications. 8: 1397-1402. DOI: 10.1016/J.Catcom.2006.11.040  0.366
2007 Xu B, Bordiga S, Prins R, van Bokhoven JA. Effect of framework Si/Al ratio and extra-framework aluminum on the catalytic activity of Y zeolite Applied Catalysis a: General. 333: 245-253. DOI: 10.1016/J.Apcata.2007.09.018  0.304
2007 Kuba MG, Prins R, Pirngruber GD. Gas-phase nitration of toluene with zeolite beta Applied Catalysis a: General. 333: 78-89. DOI: 10.1016/J.Apcata.2007.09.007  0.427
2007 Kuba MG, Prins R, Pirngruber GD. Batch and continuous nitration of toluene and chlorobenzene with acetyl nitrate over zeolite beta Applied Catalysis a: General. 333: 24-29. DOI: 10.1016/J.Apcata.2007.08.039  0.371
2007 Niquille-Röthlisberger A, Prins R. Influence of nitrogen-containing components on the hydrodesulfurization of 4,6-dimethyldibenzothiophene over Pt, Pd, and Pt-Pd on alumina catalysts Topics in Catalysis. 46: 65-78. DOI: 10.1007/S11244-007-0316-6  0.421
2006 Yang S, Liang C, Prins R. New synthesis method for metal phosphide hydrotreating catalysts : MoP/SiO2 and MoP/Al2O3 Studies in Surface Science and Catalysis. 162: 307-314. DOI: 10.1016/S0167-2991(06)80921-3  0.41
2006 Xu B, Sievers C, Hong SB, Prins R, van Bokhoven JA. Catalytic activity of Brønsted acid sites in zeolites: Intrinsic activity, rate-limiting step, and influence of the local structure of the acid sites Journal of Catalysis. 244: 163-168. DOI: 10.1016/J.Jcat.2006.08.022  0.325
2006 Niquille-Röthlisberger A, Prins R. Hydrodesulfurization of 4,6-dimethyldibenzothiophene and dibenzothiophene over alumina-supported Pt, Pd, and Pt-Pd catalysts Journal of Catalysis. 242: 207-216. DOI: 10.1016/J.Jcat.2006.06.009  0.4
2006 Yang S, Liang C, Prins R. Preparation and hydrotreating activity of unsupported nickel phosphide with high surface area Journal of Catalysis. 241: 465-469. DOI: 10.1016/J.Jcat.2006.05.014  0.397
2006 Egorova M, Prins R. The role of Ni and Co promoters in the simultaneous HDS of dibenzothiophene and HDN of amines over Mo/γ-Al2O3 catalysts Journal of Catalysis. 241: 162-172. DOI: 10.1016/J.Jcat.2006.04.011  0.458
2006 Zhao Y, Sivasankar N, Czyzniewska J, Kukula P, Prins R. Mechanism of the hydrodenitrogenation of neopentylamine and adamantylamine on sulfided NiMo/Al2O3 Catalysis Letters. 110: 221-228. DOI: 10.1007/S10562-006-0112-0  0.346
2006 Kukula P, Gramlich V, Prins R. Preparation of Partially Hydrogenated 4,6-Dimethyldibenzothiophenes Helvetica Chimica Acta. 89: 1623-1640. DOI: 10.1002/Hlca.200690162  0.385
2001 Cattaneo R, Shido T, Prins R. QEXAFS study of the sulfidation of NiMo/Al2O3 hydrotreating catalysts. Journal of Synchrotron Radiation. 8: 158-62. PMID 11512716  0.32
2001 Lindlar B, Lüchinger M, Haouas M, Kogelbauer A, Prins R. 29-P-28-Acidic hybrid catalysts prepared by grafting large-pore silica M41S materials Studies in Surface Science and Catalysis. 135: 318. DOI: 10.1016/S0167-2991(01)81723-7  0.333
2001 Marturano P, Drozdová L, Kogelbauer A, Prins R. 11-O-05 - Binuclear oxo-Fe species in Fe/ZSM-5 catalyst prepared by chemical vapour deposition Studies in Surface Science and Catalysis. 135: 143. DOI: 10.1016/S0167-2991(01)81223-4  0.318
2001 Rota F, Prins R. Role of hydrogenolysis and nucleophilic substitution in hydrodenitrogenation over sulfided NiMo/γ-Al2O3 Journal of Catalysis. 202: 195-199. DOI: 10.1006/Jcat.2001.3277  0.364
2001 Ramaswamy V, Tripathi B, Srinivas D, Ramaswamy AV, Cattaneo R, Prins R. Structure and redox behavior of zirconium in microporous Zr-silicalites studied by EXAFS and ESR techniques Journal of Catalysis. 200: 250-258. DOI: 10.1006/Jcat.2001.3213  0.301
2001 Cattaneo R, Rota F, Prins R. An XAFS Study of the Different Influence of Chelating Ligands on the HDN and HDS of γ-Al2O3-Supported NiMo Catalysts Journal of Catalysis. 199: 318-327. DOI: 10.1006/Jcat.2001.3170  0.433
2000 Ranade VS, Prins R. Hydrogenolysis of benzylic alcohols on rhodium catalysts. Chemistry (Weinheim An Der Bergstrasse, Germany). 6: 313-20. PMID 11931111 DOI: 10.1002/(SICI)1521-3765(20000117)6:2<313::AID-CHEM313>3.0.CO;2-9  0.307
2000 Vassena D, Kogelbauer A, Prins R. The highly selective conversion of toluene into 4-nitrotoluene and 2,4-dinitrotoluene using zeolite H-beta Studies in Surface Science and Catalysis. 130: 515-520. DOI: 10.1016/S0167-2991(00)81009-5  0.32
2000 Cattaneo R, Weber T, Shido T, Prins R. A Quick EXAFS Study of the Sulfidation of NiMo/SiO2 Hydrotreating Catalysts Prepared with Chelating Ligands Journal of Catalysis. 191: 225-236. DOI: 10.1006/Jcat.1999.2784  0.4
1999 Cattaneo R, Shido T, Prins R. A XANES temperature-programmed sulphidation study of modified NiMo/SiO2 hydrotreating catalysts Studies in Surface Science and Catalysis. 127: 421-425. DOI: 10.1016/S0167-2991(99)80444-3  0.404
1999 Vassena D, Kogelbauer A, Prins R. Selective nitration of toluene with acetyl nitrate and zeolites Studies in Surface Science and Catalysis. 125: 501-506. DOI: 10.1016/S0167-2991(99)80252-3  0.357
1999 Cattaneo R, Shido T, Prins R. The Relationship between the Structure of NiMo/SiO2 Catalyst Precursors Prepared in the Presence of Chelating Ligands and the Hydrodesulfurization Activity of the Final Sulfided Catalysts Journal of Catalysis. 185: 199-212. DOI: 10.1006/Jcat.1999.2492  0.432
1998 Schildenberger M, Bonetti Y, Aeschlimann M, Scandella L, Gobrecht J, Prins R. Preparation of model catalysts by laser interference nanolithography followed by metal cluster deposition Catalysis Letters. 56: 1-6. DOI: 10.1023/A:1019080222823  0.335
1996 Kraus H, Prins R, Kentgens APM. A 27Al MQMAS and Off-Resonance Nutation NMR Investigation of Mo−P/γ-Al2O3 Hydrotreating Catalyst Precursors The Journal of Physical Chemistry. 100: 16336-16345. DOI: 10.1021/Jp961574M  0.35
1996 Gotti A, Prins R. Effect of metal oxide additives on the CO hydrogenation to methanol over Rh/SiO2 and Pd/SiO2 Catalysis Letters. 37: 143-151. DOI: 10.1007/Bf00807745  0.396
1995 Bertea L, Kouwenhoven HW, Prins R. Vapour-phase nitration of benzene over modified mordenite catalysts Applied Catalysis a-General. 129: 229-250. DOI: 10.1016/0926-860X(95)00105-0  0.451
1995 Jian M, Prins R. The effect of phosphorus on the HDN reaction of piperidine, decahydroquinoline and ortho-propylaniline over Ni-MoS2/Al2O3 catalysts Catalysis Letters. 35: 193-203. DOI: 10.1007/Bf00807176  0.463
1995 Stamm T, Kouwenhoven H, Seebach D, Prins R. Zeolite-Catalyzed Isomerization of Aromatic Amines to Methyl-Aza-Aromatics Journal of Catalysis. 155: 268-282. DOI: 10.1006/Jcat.1995.1209  0.34
1994 Bertea LE, Kouwenhoven HW, Prins R. Vapour-Phase Nitration of Benzene over Zeolitic Catalysts Studies in Surface Science and Catalysis. 84: 1973-1980. DOI: 10.1016/S0167-2991(08)63757-X  0.427
1994 Lanini S, Prins R. Deactivation during the hydrogenation of 2-methylglutaronitrile to β-picoline Studies in Surface Science and Catalysis. 88: 483-490. DOI: 10.1016/S0167-2991(08)62776-7  0.335
1994 Borer AL, Bronnimann C, Prins R. ZrO2-Promoted Rh/SiO2 Catalysts in CO Hydrogenation and Temperature-Programmed Reduction Journal of Catalysis. 145: 516-525. DOI: 10.1006/Jcat.1994.1062  0.446
1993 Borer AL, Prins R. The Promoting Effect of La2O3 on the CO Hydrogenation Over Rh/SiO2 Studies in Surface Science and Catalysis. 75: 765-779. DOI: 10.1016/S0167-2991(08)64055-0  0.447
1993 Bertea LE, Kouwenhoven HW, Prins R. Catalytic vapour-phase nitration of benzene over modified Y zeolites: influence of catalyst treatment Studies in Surface Science and Catalysis. 78: 607-614. DOI: 10.1016/S0167-2991(08)63373-X  0.427
1993 Stamm T, Kouwenhoven HW, Prins R. Zeolite Catalysed Rearrangement of Aromatic Amines Studies in Surface Science and Catalysis. 78: 543-550. DOI: 10.1016/S0167-2991(08)63364-9  0.377
1993 Borer AL, Prins R. Temperature-Programmed Reduction and CO Hydrogenation of La2O3-Promoted Rh/SiO2 Catalysts Journal of Catalysis. 144: 439-451. DOI: 10.1006/Jcat.1993.1344  0.448
1992 Schultz E, Borer AL, Prins R. EXAFS investigations of lanthana-promoted Rh/SiO2 catalysts Catalysis Letters. 14: 279-288. DOI: 10.1007/Bf00769665  0.437
1991 Kisfaludi G, Leyrer J, Knözinger H, Prins R. An EXAFS study of the spreading of MoO3 on the surface of γ-Al2O3 Journal of Catalysis. 130: 192-201. DOI: 10.1016/0021-9517(91)90103-B  0.307
1985 Koningsberger DC, Van Zon JBAD, Van't Blik HFJ, Visser GJ, Prins R, Mansour AN, Sayers DE, Short DR, Katzer JR. An extended x-ray absorption fine structure study of rhodium-oxygen bonds in a highly dispersed rhodium/aluminum oxide catalyst The Journal of Physical Chemistry. 89: 4075-4081. DOI: 10.1021/J100265A030  0.375
1985 KONINGSBERGER DC, VAN ZON JBAD, VAN'T BLIK HFJ, VISSER GJ, PRINS R, MANSOUR AN, SAYERS DE, SHORT DR, KATZER JR. ChemInform Abstract: AN EXTENDED X-RAY ABSORPTION FINE STRUCTURE STUDY OF RHODIUM-OXYGEN BONDS IN A HIGHLY DISPERSED RHODIUM/ALUMINUM OXIDE CATALYST Chemischer Informationsdienst. 16. DOI: 10.1002/Chin.198551012  0.379
1983 Blik HFJV, Zon JBADV, Huizinga T, Vis JC, Koningsberger DC, Prins R. An Extended X-Ray Absorption Fine Structure Spectroscopy Study Of A Highly Dispersed Rhodium/Aluminum Oxide Catalyst: The Influence Of Carbon Monoxide Chemisorption On The Topology Of Rhodium Cheminform. 14. DOI: 10.1002/Chin.198339006  0.355
Low-probability matches (unlikely to be authored by this person)
2006 XU B, ROTUNNO F, BORDIGA S, PRINS R, VANBOKHOVEN J. Reversibility of structural collapse in zeolite Y: Alkane cracking and characterization Journal of Catalysis. 241: 66-73. DOI: 10.1016/J.Jcat.2006.04.009  0.297
2002 Egorova M, Zhao Y, Kukula P, Prins R. On the Role of β Hydrogen Atoms in the Hydrodenitrogenation of 2-Methylpyridine and 2-Methylpiperidine Journal of Catalysis. 206: 263-271. DOI: 10.1006/Jcat.2001.3486  0.293
2009 Prins R. New catalysts for hydrodesulfurization Acs National Meeting Book of Abstracts.  0.292
1999 Marturano P, Kogelbauer A, Prins R. Different methods for preparation of Fe-ZSM5 as catalyst for the selective catalytic reduction of nitrogen oxides Studies in Surface Science and Catalysis. 125: 619-625. DOI: 10.1016/S0167-2991(99)80267-5  0.29
2019 Prins R. Location of the Spinel Vacancies in γ-Al2O3. Angewandte Chemie (International Ed. in English). PMID 31194902 DOI: 10.1002/Anie.201901497  0.289
2020 Zhou X, Li X, Prins R, Wang A, Wang L, Liu S, Sheng Q. Desulfurization of 2-phenylcyclohexanethiol over transition-metal phosphides Journal of Catalysis. 383: 331-342. DOI: 10.1016/J.Jcat.2020.01.023  0.288
1998 Hitz S, Kogelbauer A, Lindlar B, Prins R. Influence of pH adjustment on structure, stability, and catalytic activity of Al-MCM-41 mesoporous molecular sieves Studies in Surface Science and Catalysis. 117: 519-525. DOI: 10.1016/S0167-2991(98)81033-1  0.287
2016 Li X, Feng J, Guo J, Wang A, Prins R, Duan X, Chen Y. Preparation of Ni2P/Al2O3 by temperature-programmed reduction of a phosphate precursor with a low P/Ni ratio Journal of Catalysis. 334: 116-119. DOI: 10.1016/J.Jcat.2015.11.007  0.285
2009 Prins RP, Wang H, Sun Y. Hydrodesulfurization mechanisms and new catalysts Acs National Meeting Book of Abstracts.  0.285
2005 Weiher N, Bus E, Gorzolnik B, Möller M, Prins R, van Bokhoven JA. An in situ and operando X-ray absorption spectroscopy setup for measuring sub-monolayer model and powder catalysts. Journal of Synchrotron Radiation. 12: 675-9. PMID 16120994 DOI: 10.1107/S0909049505020261  0.279
2006 Bus E, Miller JT, Kropf AJ, Prins R, van Bokhoven JA. Analysis of in situ EXAFS data of supported metal catalysts using the third and fourth cumulant. Physical Chemistry Chemical Physics : Pccp. 8: 3248-58. PMID 16902717 DOI: 10.1039/B605248G  0.277
2008 Wang H, Prins R. On the formation of pentylpiperidine in the hydrodenitrogenation of pyridine Catalysis Letters. 126: 1-9. DOI: 10.1007/S10562-008-9615-1  0.275
2013 Bai J, Li X, Wang A, Prins R, Wang Y. Different role of H2S and dibenzothiophene in the incorporation of sulfur in the surface of bulk MoP during hydrodesulfurization Journal of Catalysis. 300: 197-200. DOI: 10.1016/J.Jcat.2013.01.015  0.275
2004 van Bokhoven JA, van der Eerden AM, Prins R. Local structure of the zeolitic catalytically active site during reaction. Journal of the American Chemical Society. 126: 4506-7. PMID 15070354 DOI: 10.1021/ja031755j  0.272
2009 Abraham A, Prins R, van Bokhoven JA, van Eck ER, Kentgens AP. TRAPDOR double-resonance and high-resolution MAS NMR for structural and template studies in zeolite ZSM-5. Solid State Nuclear Magnetic Resonance. 35: 61-6. PMID 19297136 DOI: 10.1016/J.Ssnmr.2009.01.004  0.271
2017 Liu D, Li X, Wei L, Zhang T, Wang A, Liu C, Prins R. Disproportionation of hypophosphite and phosphite. Dalton Transactions (Cambridge, England : 2003). PMID 28466903 DOI: 10.1039/C7Dt00243B  0.269
1992 Schultz E, Ferrini C, Prins R. X-ray absorption investigations on Ti-containing zeolites Catalysis Letters. 14: 221-231. DOI: 10.1007/Bf00765235  0.263
2018 Prins R. Eley–Rideal, the Other Mechanism Topics in Catalysis. 61: 714-721. DOI: 10.1007/S11244-018-0948-8  0.262
1998 Kraus H, Muller M, Prins R, Kentgens APM. Comments On The 27Al Nmr Visibility Of Aluminas Journal of Physical Chemistry B. 102: 3862-3865. DOI: 10.1021/Jp972909I  0.256
2006 Sivasankar N, Prins R. Reactions of mixed dialkyl- and trialkylamines over Pd/γ-Al2O3 Journal of Catalysis. 241: 342-355. DOI: 10.1016/J.Jcat.2006.04.032  0.249
1995 Eck ERHv, Kentgens APM, Kraus H, Prins R. A Solid State Double Resonance NMR Investigation of Phosphorus-Impregnated .gamma.-Al2O3 The Journal of Physical Chemistry. 99: 16080-16086. DOI: 10.1021/J100043A057  0.247
2007 Kukula P, Dutly A, Rüegger H, Prins R. Molecular rearrangement in the Birch reduction of dibenzothiophenes Tetrahedron Letters. 48: 5657-5659. DOI: 10.1016/J.Tetlet.2007.06.026  0.244
2004 Jerdev DI, Prins R, Koel BE. Alloy formation and CO adsorption on bimetallic Ca/Pd(111) surfaces Journal of Physical Chemistry B. 108: 14417-14427. DOI: 10.1021/Jp049817V  0.242
2006 Pirngruber GD, Roy PK, Prins R. On determining the nuclearity of iron sites in Fe-ZSM-5--a critical evaluation. Physical Chemistry Chemical Physics : Pccp. 8: 3939-50. PMID 17028684 DOI: 10.1039/B606205A  0.239
1999 Ranade VS, Consiglio G, Prins R. Functional-Group-Directed Diastereoselective Hydrogenation of Aromatic Compounds. 1. The Journal of Organic Chemistry. 64: 8862-8867. PMID 11674790  0.235
2001 Prins R. Buchbesprechung: Hydrodesulfurization and Hydrodenitrogenation. Von Toshiaki Kabe, Atsushui Ishiara und Weihua Qian. Angewandte Chemie. 113: 647-648. DOI: 10.1002/1521-3757(20010202)113:3<647::Aid-Ange647>3.0.Co;2-7  0.231
1996 Schumacher A, Kruse N, Prins R, Meyer E, Lüthi R, Howald L, Güntherodt H‐, Scandella L. Influence of humidity on friction measurements of supported MoS2 single layers Journal of Vacuum Science & Technology B. 14: 1264-1267. DOI: 10.1116/1.588528  0.228
2006 Sivasankar N, Prins R. Iminium cations as intermediates in the hydrodenitrogenation of alkylamines over sulfided NiMo/γ-Al2O3 Catalysis Today. 116: 542-553. DOI: 10.1016/J.Cattod.2006.06.027  0.228
2021 Sheng Q, Li X, Prins R, Liu C, Hao Q, Chen S. Understanding the Reduction of Transition-metal Phosphates to Transition-metal Phosphides by Combining Temperature-programmed Reduction and Infrared Spectroscopy. Angewandte Chemie (International Ed. in English). PMID 33656230 DOI: 10.1002/anie.202100767  0.218
2008 Prins R, Sun Y. Zeolites with mesopores and mesoporous zeolites Acs National Meeting Book of Abstracts.  0.216
2007 Xu B, Sievers C, Lercher JA, Van Veen JAR, Giltay P, Prins R, Van Bokhoven JA. Strong Brønsted acidity in amorphous silica - Aluminas Journal of Physical Chemistry C. 111: 12075-12079. DOI: 10.1021/Jp073677I  0.216
2005 Omegna A, Prins R, van Bokhoven JA. Effect of temperature on aluminum coordination in zeolites H-Y and H-USY and amorphous silica-alumina: an in situ Al K edge XANES study. The Journal of Physical Chemistry. B. 109: 9280-3. PMID 16852109 DOI: 10.1021/jp050086o  0.207
1997 Binder G, Scandella L, Kritzenberger J, Gobrecht J, Koegler JH, Prins R. Three-Dimensional Ordering of Molecules: p-Nitroaniline in Aligned ZSM-5 Single Crystals Journal of Physical Chemistry B. 101: 483-490. DOI: 10.1021/Jp962029O  0.205
1994 Scandella L, Schumacher A, Kruse N, Prins R, Meyer E, Lüthi R, Howald L, Güntherodt H-. Tribology of ultra-thin MoS2 platelets on mica: studies by scanning force microscopy Thin Solid Films. 240: 101-104. DOI: 10.1016/0040-6090(94)90703-X  0.201
2012 Prins R, Palfi VK, Reiher M. Hydrogen spillover to nonreducible supports Journal of Physical Chemistry C. 116: 14274-14283. DOI: 10.1021/Jp212274Y  0.198
2005 Yang S, Prins R. New synthesis method for nickel phosphide hydrotreating catalysts. Chemical Communications (Cambridge, England). 4178-80. PMID 16100595 DOI: 10.1039/b507940c  0.194
2012 Prins R. Hydrogen spillover. Facts and fiction. Chemical Reviews. 112: 2714-38. PMID 22324402 DOI: 10.1021/cr200346z  0.193
2012 Prins R. Hydrogen spillover. Facts and fiction Chemical Reviews. 112: 2714-2738. DOI: 10.1021/cr200346z  0.193
2008 Prins R, Wang H. Hydrodesulfurization for cleaner air: HDS of dibenzothiophene and its hydrogenated intermediates over sulfided Mo/g-Al2O3 Acs National Meeting Book of Abstracts.  0.189
2019 Prins R. Positionen von Spinellfehlstellen in γ‐Al2O3 Angewandte Chemie. 131: 15694-15698. DOI: 10.1002/Ange.201901497  0.186
2001 Prins R. Book Review: Hydrodesulfurization and Hydrodenitrogenation. By Toshiaki Kabe, Atsushui Ishihara and Weihua Qian. Angewandte Chemie. 40: 1551-1551. DOI: 10.1002/1521-3773(20010417)40:8<1551::Aid-Anie1551>3.0.Co;2-G  0.171
2007 Todorova T, Prins R, Weber T. A density functional theory study of the hydrogenolysis and elimination reactions of C2H5SH on the catalytically active (100) edge of 2H-MoS2 Journal of Catalysis. 246: 109-117. DOI: 10.1016/j.jcat.2006.11.023  0.146
2006 Abraham A, Prins R, van Bokhoven JA, van Eck ER, Kentgens AP. Multinuclear solid-state high-resolution and 13C -{27Al} double-resonance magic-angle spinning NMR studies on aluminum alkoxides. The Journal of Physical Chemistry. B. 110: 6553-60. PMID 16570954 DOI: 10.1021/jp055058k  0.127
2012 Prins RC, Gladwin M, Brod LS, Bhardwaj A, Hunter AJ. Chance favors the prepared mind Journal of Hospital Medicine. 7: 717-720. PMID 23024002 DOI: 10.1002/Jhm.1976  0.124
2003 Prins RM, Graf MR, Merchant RE, Black KL, Wheeler CJ. Journal of Neuro-Oncology. 64: 45-54. DOI: 10.1023/A:1024929724736  0.12
2009 Li XF, Prins R, van Bokhoven JA. Synthesis and characterization of mesoporous mordenite Journal of Catalysis. 262: 257-265. DOI: 10.1016/j.jcat.2009.01.001  0.118
2007 Frunz L, Prins R, Pirngruber GD. Mimicking the active center of methane-monooxygenase by metal-peptide complexes immobilized on mesoporous silica Chemistry of Materials. 19: 4357-4366. DOI: 10.1021/cm070686v  0.11
2021 Jingwen Y, Hagiwara A, Oughourlian T, Wang C, Raymond C, Pope W, Salamon N, Lai A, Nghiemphu P, Everson R, Kim W, Prins R, Liau L, Cloughesy T, Nathanson D, et al. NIMG-44. PROGNOSTIC VALUE OF PH- AND OXYGEN-SENSITIVE MRI IN GLIOMA PATIENTS Neuro-Oncology. 23: vi138-vi139. DOI: 10.1093/neuonc/noab196.543  0.083
2020 Prins R, Galvez M, Amouzgar M, Campbell K, Wells D, Bayless N, Everson R, Cloughesy T. CTIM-19. MOLECULAR AND GENETIC DETERMINANTS OF RESPONSE TO PD-1 BLOCKADE IN RECURRENT GLIOBLASTOMA PATIENTS Neuro-Oncology. 22: ii37-ii37. DOI: 10.1093/neuonc/noaa215.153  0.082
2021 Arrieta V, Chen AX, Kane JR, Kang SJ, Kassab C, Dmello C, Zhao J, Burdett K, Upadhyayula P, Chang C, Shilati J, Jaishankar D, Chen L, Gould A, Zhang D, ... ... Prins R, et al. BIOM-31. ERK1/2 PHOSPHORYLATION PREDICTS SURVIVAL FOLLOWING ANTI-PD-1 IMMUNOTHERAPY IN RECURRENT GLIOBLASTOMA Neuro-Oncology. 23: vi17-vi17. DOI: 10.1093/neuonc/noab196.062  0.082
2014 Antonios J, Soto H, Harris R, Nathanson D, Sadeghi S, Ellingson B, Liau L, Prins R. IT-01 * PD1/PDL1 INTERACTIONS MEDIATE SUPPRESSION OF ANTI-TUMOR IMMUNE ACTIVITY IN GLIOMA Neuro-Oncology. 16: v110-v110. DOI: 10.1093/Neuonc/Nou258.1  0.076
2018 Davidson TB, Lee AH, Hsu M, Sedighim S, Orpilla J, Treger J, Mastall M, Roesch S, Rapp C, Galvez M, Mochizuki AY, Antonios JP, Garcia AJ, Kotecha N, Bayless NL, ... ... Prins RM, et al. Expression of PD-1 by T cells in malignant glioma patients reflects exhaustion and activation. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30498094 DOI: 10.1158/1078-0432.Ccr-18-1176  0.075
2018 Hu-Lieskovan S, Torrejon DY, Zaretsky JM, Tsoi J, Cheung-Lau G, Vega-Crespo A, Meeth K, Prins RM, Graeber T, Besenberg M, Grasso C, Comin-Anduix B, Ribas A. Role of CD4 cells in the complete anti-tumor response to PD1 blockade in a syngeneic murine melanoma model with activated WNT signaling. Journal of Clinical Oncology. 36: 12013-12013. DOI: 10.1200/Jco.2018.36.15_Suppl.12013  0.074
2016 Antonios JP, Soto H, Everson RG, Orpilla J, Moughon D, Shin N, Sedighim S, Yong WH, Li G, Cloughesy TF, Liau LM, Prins RM. PD-1 blockade enhances the vaccination-induced immune response in glioma. Jci Insight. 1. PMID 27453950 DOI: 10.1172/Jci.Insight.87059  0.073
2019 Yao J, Nathanson D, Yong WH, Salamon N, Lai A, Leia Nghiemphu P, Prins R, Pope W, Czernin J, Everson R, Liau L, Cloughesy T, Ellingson B. NIMG-60. IDH MUTANT GLIOMAS WITH 1p/19q CO-DELETION ARE LESS ACIDIC THAN NON-CO-DELETED GLIOMAS AS MEASURED WITH PH-WEIGHTED AMINE CEST-MRI AND AMINO ACID PET Neuro-Oncology. 21: vi174-vi175. DOI: 10.1093/Neuonc/Noz175.729  0.072
2019 Chow F, Mochizuki A, Lee A, Galvez M, Orpilla J, Everson R, Liau L, Cloughesy T, Prins R. ATIM-16. VALIDATION OF RESPONSE TO NEOADJUVANT ANTI-PD-1 IMMUNOTHERAPY IN RECURRENT GLIOBLASTOMA Neuro-Oncology. 21: vi4-vi5. DOI: 10.1093/Neuonc/Noz175.016  0.072
2016 Davidson T, Hsu M, Sedighim S, Moughon D, Yong W, Liau L, Prins R. ATIM-26. PD-1 EXPRESSION BY TUMOR INFILTRATING LYMPHOCYTES IN GLIOBLASTOMA IS A MARKER OF BOTH ACTIVATION AND EXHAUSTION Neuro-Oncology. 18: vi23-vi23. DOI: 10.1093/Neuonc/Now212.091  0.071
2020 Sun L, Kienzler J, Lee A, Chow F, Chavez C, Yong W, Everson R, Kim W, Hugo W, Prins R. TAMI-01. NEOADJUVANT PD-1 ANTIBODY BLOCKADE REMODELS THE IMMUNE MICROENVIRONMENT OF METASTATIC BRAIN TUMORS Neuro-Oncology. 22: ii212-ii213. DOI: 10.1093/neuonc/noaa215.890  0.07
2012 Chou AP, Chowdhury R, Li S, Chen W, Kim AJ, Piccioni DE, Selfridge JM, Mody RR, Chang S, Lalezari S, Lin J, Sanchez DE, Wilson RW, Garrett MC, Harry B, ... ... Prins RM, et al. Identification of retinol binding protein 1 promoter hypermethylation in isocitrate dehydrogenase 1 and 2 mutant gliomas. Journal of the National Cancer Institute. 104: 1458-69. PMID 22945948 DOI: 10.1093/Jnci/Djs357  0.07
2019 Cloughesy TF, Mochizuki AY, Orpilla JR, Hugo W, Lee AH, Davidson TB, Wang AC, Ellingson BM, Rytlewski JA, Sanders CM, Kawaguchi ES, Du L, Li G, Yong WH, Gaffey SC, ... ... Prins RM, et al. Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma. Nature Medicine. PMID 30742122 DOI: 10.1038/S41591-018-0337-7  0.07
2015 Harris RJ, Cloughesy TF, Liau LM, Prins RM, Antonios JP, Li D, Yong WH, Pope WB, Lai A, Nghiemphu PL, Ellingson BM. pH-weighted molecular imaging of gliomas using amine chemical exchange saturation transfer MRI. Neuro-Oncology. PMID 26113557 DOI: 10.1093/Neuonc/Nov106  0.069
2009 Vo DD, Prins RM, Begley JL, Donahue TR, Morris LF, Bruhn KW, de la Rocha P, Yang MY, Mok S, Garban HJ, Craft N, Economou JS, Marincola FM, Wang E, Ribas A. Enhanced antitumor activity induced by adoptive T-cell transfer and adjunctive use of the histone deacetylase inhibitor LAQ824. Cancer Research. 69: 8693-9. PMID 19861533 DOI: 10.1158/0008-5472.Can-09-1456  0.069
2021 Lee AH, Sun L, Mochizuki AY, Reynoso JG, Orpilla J, Chow F, Kienzler JC, Everson RG, Nathanson DA, Bensinger SJ, Liau LM, Cloughesy T, Hugo W, Prins RM. Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma. Nature Communications. 12: 6938. PMID 34836966 DOI: 10.1038/s41467-021-26940-2  0.069
2019 Mochizuki A, Lee A, Orpilla J, Kienzler J, Galvez M, Chow F, Davidson T, Wang A, Everson R, Liau L, Cloughesy T, Prins R. TMIC-06. MYELOID POPULATIONS AND THE EFFECT OF NEOADJUVANT PD-1 INHIBITION IN THE GLIOBLASTOMA MICROENVIRONMENT: A SURFACEOMIC AND TRANSCRIPTOMIC DISSECTION AT THE SINGLE-CELL LEVEL Neuro-Oncology. 21: vi248-vi248. DOI: 10.1093/Neuonc/Noz175.1040  0.068
2010 Fantin VR, Dang L, White DW, Gross S, Bittinger MA, Driggers EM, Jang HG, Jin S, Keenan MC, Marks KM, Yen KE, Ward PS, Prins RM, Liau LM, Bennett BD, et al. Abstract 33: Cancer-associated IDH1 mutations produce 2-hydroxyglutarate Cancer Research. 70: 33-33. DOI: 10.1158/1538-7445.Am10-33  0.068
2017 Antonios JP, Soto H, Everson RG, Moughon D, Orpilla JR, Shin NP, Sedighim S, Treger J, Odesa S, Tucker A, Yong WH, Li G, Cloughesy TF, Liau LM, Prins RM. Immunosuppressive tumor-infiltrating myeloid cells mediate adaptive immune resistance via a PD-1/PD-L1 mechanism in glioblastoma. Neuro-Oncology. PMID 28115578 DOI: 10.1093/Neuonc/Now287  0.068
2021 Lee A, Sun L, Mochizuki A, Reynoso J, Orpilla J, Chow F, Kienzler J, Everson R, Nathanson D, Liau L, Cloughesy T, Hugo W, Prins R. IMMU-41. NEOADJUVANT PD-1 BLOCKADE INDUCES T CELL AND CDC1 ACTIVATION BUT FAILS TO OVERCOME THE IMMUNOSUPPRESSIVE TUMOR ASSOCIATED MACROPHAGES IN RECURRENT GLIOBLASTOMA Neuro-Oncology. 23: vi101-vi101. DOI: 10.1093/neuonc/noab196.400  0.066
2020 Davidson T, Hugo W, Wang A, Kim J, Li G, Prins R. IMMU-30. UPREGULATED T CELL AND INTERFERON-Γ-RELATED GENE EXPRESSION IS ASSOCIATED WITH INCREASED SURVIVAL IN RECURRENT PEDIATRIC HIGH-GRADE GLIOMA Neuro-Oncology. 22: iii365-iii366. DOI: 10.1093/neuonc/noaa222.384  0.066
2020 Lee A, Mochizuki A, Chow F, Reynoso J, Orpilla J, Sun L, Chavez C, Galvez M, Kienzler J, Yong W, Everson R, Nathanson D, Bensinger S, Liau L, Cloughesy T, ... ... Prins R, et al. IMMU-20. SINGLE-CELL RNASEQ OF TUMOR INFILTRATING IMMUNE CELLS FROM NEOADJUVANT ANTI-PD1 TREATED GBM PATIENTS REVEALS GLOBAL TRANSCRIPTIONAL CHANGES AND IMMUNOSUPPRESSIVE ADAPTIVE RESPONSES BY MYELOID CELLS Neuro-Oncology. 22: ii108-ii109. DOI: 10.1093/neuonc/noaa215.450  0.065
2013 Prins RC, Burke RT, Tyner JW, Druker BJ, Loriaux MM, Spurgeon SE. CX-4945, a selective inhibitor of casein kinase-2 (CK2), exhibits anti-tumor activity in hematologic malignancies including enhanced activity in chronic lymphocytic leukemia when combined with fludarabine and inhibitors of the B-cell receptor pathway Leukemia. 27: 2094-2096. PMID 23900138 DOI: 10.1038/Leu.2013.228  0.065
2020 Lee E, Muzikansky A, Arrillaga-Romany I, Chukwueke U, Cloughesy T, Colman H, Daras M, de Groot J, Mcfaline-Figueroa J, Nayak L, Prins R, Reardon D, Taylor J, Ligon K, Wen P. CTNI-47. PHASE II STUDY OF ABEMACICLIB IN RECURRENT GBM PATIENTS WITH CDKN2A/B LOSS AND INTACT RB Neuro-Oncology. 22: ii53-ii53. DOI: 10.1093/neuonc/noaa215.213  0.064
2015 Pelargos P, Qin Y, Voth B, Thill K, Chung L, Prins R, Liau L, Ung N, Hojat S, Yong W, Gordon L, Wadehra M, Yang I. ATPS-62TARGETING OF NOVEL GBM BIOMARKER EMP2 RESULTS IN DECREASED TUMOR GROWTH AND INCREASED TUMOR NECROSIS Neuro-Oncology. 17: v31.5-v32. DOI: 10.1093/Neuonc/Nov204.62  0.064
2014 Garrett MC, Mottahedeh J, Sperry J, Eskin A, Coppola G, Shih Y, Lai A, Chou A, Liau L, Prins R, Cloughesy T, Wu H, Nelson S, Kornblum H. Abstract 447: The IDH1 mutation in human glioblastoma and its effects on epigenetic modification and cell fate selection Cancer Research. 74: 447-447. DOI: 10.1158/1538-7445.Am2014-447  0.064
2021 Morrow D, Minami J, Bayley N, Williams K, Bensinger S, Prins R, Liau L, Cloughesy T, Nathanson D. DDRE-23. A COMPREHENSIVE CHARACTERIZATION OF THE GBM LIPIDOME REVEALS A MOLECULARLY-DEFINED SUB-GROUP WITH HEIGHTENED SENSITIVITY TO LIPID PEROXIDATION INDUCED CELL DEATH Neuro-Oncology Advances. 3: i11-i11. DOI: 10.1093/noajnl/vdab024.045  0.063
2021 Peeters S, Chen Z, Obenchain R, Haist B, Prins R, Liau L, Wirz R, Wang A. EXTH-11. COLD ATMOSPHERIC PLASMA SELECTIVELY INDUCES APOPTOSIS AND FERROPTOSIS THROUGH REACTIVE OXYGEN SPECIES IN HIGH-GRADE GLIOMA Neuro-Oncology. 23: vi165-vi165. DOI: 10.1093/neuonc/noab196.650  0.062
2019 Morrow D, Bayley N, Williams K, Muranaka H, Prins R, Liau L, Cloughesy T, Bensinger S, Nathanson D. CBMT-43. INTEGRATED LIPIDOMIC AND MOLECULAR ANALYSIS REVEALS A SUBSET OF GLIOBLASTOMA VULNERABLE TO FERROPTOSIS Neuro-Oncology. 21: vi42-vi42. DOI: 10.1093/Neuonc/Noz175.165  0.062
2018 Mochizuki A, Orpilla J, Lee A, Garcia A, Liau L, Cloughesy T, Prins R. IMMU-28. HIGH-DIMENSIONAL SINGLE CELL CHARACTERIZATION OF THE SYSTEMIC INFLUENCE OF NEOADJUVANT PD-1 BLOCKADE IN PATIENTS WITH RECURRENT GLIOBLASTOMA Neuro-Oncology. 20: vi127-vi127. DOI: 10.1093/Neuonc/Noy148.531  0.062
2012 Pope WB, Prins RM, Albert Thomas M, Nagarajan R, Yen KE, Bittinger MA, Salamon N, Chou AP, Yong WH, Soto H, Wilson N, Driggers E, Jang HG, Su SM, Schenkein DP, et al. Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy. Journal of Neuro-Oncology. 107: 197-205. PMID 22015945 DOI: 10.1007/S11060-011-0737-8  0.061
2005 Liau LM, Prins RM, Kiertscher SM, Odesa SK, Kremen TJ, Giovannone AJ, Lin JW, Chute DJ, Mischel PS, Cloughesy TF, Roth MD. Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 5515-25. PMID 16061868 DOI: 10.1158/1078-0432.CCR-05-0464  0.061
2021 Bayley N, Tse C, Zhu H, Ta L, Baufeld L, Gosa L, Yan W, Prins R, Yong W, Cloughesy T, Liau L, Graeber T, Nathanson D. EPCO-10. INTRATUMORAL HETEROGENEITY OF ENVIRONMENT-INDUCED EXPRESSION PROGRAMS IN GLIOMA PATIENTS AND DERIVED MODEL SYSTEMS Neuro-Oncology. 23: vi3-vi3. DOI: 10.1093/neuonc/noab196.009  0.061
2009 Begley J, Vo DD, Morris LF, Bruhn KW, Prins RM, Mok S, Koya RC, Garban HJ, Comin-Anduix B, Craft N, Ribas A. Immunosensitization with a Bcl-2 small molecule inhibitor. Cancer Immunology, Immunotherapy : Cii. 58: 699-708. PMID 18807035 DOI: 10.1007/S00262-008-0592-4  0.061
2015 Hickey M, Soto H, Treger J, Erickson K, Malone C, Ha E, Young E, Prins R, Liau L, Kruse C. IMCT-10A PHASE I DOSE ESCALATION STUDY TO TEST THE SAFETY OF INTRATUMORAL ADOPTIVE IMMUNE THERAPY WITH AlloCTL IN RECURRENT GLIOMA PATIENTS Neuro-Oncology. 17: v109.3-v109. DOI: 10.1093/Neuonc/Nov218.10  0.06
2009 Guo D, Hildebrandt IJ, Prins RM, Soto H, Mazzotta MM, Dang J, Czernin J, Shyy JY, Watson AD, Phelps M, Radu CG, Cloughesy TF, Mischel PS. The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis. Proceedings of the National Academy of Sciences of the United States of America. 106: 12932-7. PMID 19625624 DOI: 10.1073/Pnas.0906606106  0.059
2015 Kato Y, Scharnweber R, Inagaki A, Kamijima S, Hickey M, Lisiero D, Hermann K, Soto H, Antonios J, Sedighim S, Okada H, Liau L, Klatzmann D, Prins R, Kashara N. IMPS-19RETROVIRAL REPLICATING VECTOR-MEDIATED DELIVERY OF AN IMMUNODOMINANT NEO-ANTIGEN EPITOPE TARGET FOR VIRO-IMMUNOTHERAPY IN EXPERIMENTAL GLIOMA Neuro-Oncology. 17: v117.2-v117. DOI: 10.1093/Neuonc/Nov217.19  0.059
2017 Quandt D, Zucht HD, Amann A, Wulf-Goldenberg A, Borrebaeck C, Cannarile M, Lambrechts D, Oberacher H, Garrett J, Nayak T, Kazinski M, Massie C, Schwarzenbach H, Maio M, Prins R, et al. Implementing liquid biopsies into clinical decision making for cancer immunotherapy. Oncotarget. PMID 28501851 DOI: 10.18632/oncotarget.17397  0.058
2009 Guo D, Prins RM, Dang J, Kuga D, Iwanami A, Soto H, Lin KY, Huang TT, Akhavan D, Hock MB, Zhu S, Kofman AA, Bensinger SJ, Yong WH, Vinters HV, et al. EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy. Science Signaling. 2: ra82. PMID 20009104 DOI: 10.1126/Scisignal.2000446  0.058
2016 Sedighim S, Hsu M, Wang T, Everson RG, Tucker A, Antonios JP, Du L, Emerson R, Yusko E, Sanders C, Robins H, Yong W, Davidson TB, Li G, Liau LM, ... Prins R, et al. Abstract 767: TCR sequencing can identify and track tumor-specific T cell populations and is a predictive biomarker of response to DC vaccination in glioblastoma patients Cancer Research. 76: 767-767. DOI: 10.1158/1538-7445.Am2016-767  0.058
2018 Subbiah V, Murthy R, Hong DS, Prins RM, Hosing C, Hendricks K, Kolli D, Noffsinger L, Brown R, McGuire M, Fu S, Piha-Paul S, Naing A, Conley AP, Benjamin RS, et al. Cytokines Produced by Dendritic Cells Administered Intratumorally Correlate with Clinical Outcome in Patients with Diverse Cancers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30018119 DOI: 10.1158/1078-0432.CCR-17-2707  0.058
2005 Craft N, Bruhn KW, Nguyen BD, Prins R, Lin JW, Liau LM, Miller JF. The TLR7 agonist imiquimod enhances the anti-melanoma effects of a recombinant Listeria monocytogenes vaccine. Journal of Immunology (Baltimore, Md. : 1950). 175: 1983-90. PMID 16034143 DOI: 10.4049/Jimmunol.175.3.1983  0.058
2010 Hickey MJ, Malone CC, Erickson KL, Jadus MR, Prins RM, Liau LM, Kruse CA. Cellular and vaccine therapeutic approaches for gliomas. Journal of Translational Medicine. 8: 100. PMID 20946667 DOI: 10.1186/1479-5876-8-100  0.057
2013 Williams KJ, Argus JP, Zhu Y, Wilks MQ, Marbois BN, York AG, Kidani Y, Pourzia AL, Akhavan D, Lisiero DN, Komisopoulou E, Henkin AH, Soto H, Chamberlain BT, Vergnes L, ... ... Prins RM, et al. An essential requirement for the SCAP/SREBP signaling axis to protect cancer cells from lipotoxicity. Cancer Research. 73: 2850-62. PMID 23440422 DOI: 10.1158/0008-5472.Can-13-0382-T  0.057
2021 Lu Y, Ng AHC, Chow FE, Everson RG, Helmink BA, Tetzlaff MT, Thakur R, Wargo JA, Cloughesy TF, Prins RM, Heath JR. Resolution of tissue signatures of therapy response in patients with recurrent GBM treated with neoadjuvant anti-PD1. Nature Communications. 12: 4031. PMID 34188042 DOI: 10.1038/s41467-021-24293-4  0.057
2014 Hardy A, Prins R, Kong X, Woodworth D, Pope W, Yong W, Cloughesy T, Liau L, Ellingson B. NI-32 * ENHANCING TUMOR RESPONSE USING QUANTITATIVE VOLUMETRY FROM T1 SUBTRACTION MAPS IN MALIGNANT GLIOMA TREATED WITH DENDRITIC CELL VACCINATION Neuro-Oncology. 16: v145-v145. DOI: 10.1093/Neuonc/Nou264.30  0.057
2015 Okada H, Weller M, Huang R, Finocchiaro G, Gilbert M, Wick W, Ellingson B, Hashimoto N, Pollack I, Brandes A, Franceschi E, Herold-Mende C, Nayak L, Panigrahy A, Pope W, ... Prins R, et al. NIMG-56IMMUNOTHERAPY RESPONSE ASSESSMENT IN NEURO-ONCOLOGY (iRANO): A REPORT OF THE RANO WORKING GROUP Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov225.56  0.056
2019 Kienzler J, Reynoso J, Owens G, Orpilla J, Lee A, Mochizuki A, Yong WH, Liau L, Prins R. IMMU-33. IMMUNE PROFILING REVEALS INHIBITORY MACROPHAGES AND A DISTINCT SPATIAL DISTRIBUTION OF IMMUNE CELLS IN DIFFERENT TYPES OF BRAIN METASTASES Neuro-Oncology. 21: vi126-vi126. DOI: 10.1093/Neuonc/Noz175.525  0.055
2003 Prins RM, Liau LM. Immunology and immunotherapy in neurosurgical disease. Neurosurgery. 53: 144-52; discussion 1. PMID 12823883 DOI: 10.1227/01.neu.0000068865.34216.3a  0.055
2006 Kimura T, Hejing W, Koya R, Faure-Kumar E, Prins R, Comin-Anduix B, Cui Y, Kasahara N, Stripecke R. 993. Optical Bioluminescence and Immunologic Analyses of Lentiviral Vectors Administered In Vivo: Transcriptional Targeting through an MHCII Promoter Yields Persistent Transgene Expression and Lack of CTL Stimulation in Immunocompetent Mice Indicating Tolerance Molecular Therapy. 13. DOI: 10.1016/J.Ymthe.2006.08.1086  0.055
2011 Dauer LT, Thornton R, Boylan DC, Holahan B, Prins R, Quinn B, St Germain J. Organ and effective dose estimates for patients undergoing hepatic arterial embolization for treatment of liver malignancy. Medical Physics. 38: 736-42. PMID 21452711 DOI: 10.1118/1.3533685  0.055
2021 Lai T, Treger J, Rao J, Li T, Lai A, Prins R, Everson R. ECOA-2. Immuno-sensitization of Glioblastoma to NY-ESO-1 Targeting via Promoter Demethylation Neuro-Oncology Advances. 3: ii1-ii1. DOI: 10.1093/NOAJNL/VDAB070.002  0.054
2015 Bosch M, Prins R, Liau L. Abstract 2491: Treatment with tumor lysate-pulsed autologous dendritic cells prolongs survival in patients with recurrent glioblastoma multiforme Cancer Research. 75: 2491-2491. DOI: 10.1158/1538-7445.Am2015-2491  0.054
2021 Hagiwara A, Jingwen Y, Oughourlian T, Wang C, Raymond C, Everson R, Patel K, Mareninov S, Yong W, Salamon N, Pope W, Nghiemphu P, Liau L, Prins R, Cloughesy T, et al. NIMG-45. DIFFUSION MRI AS AN EARLY BIOMARKER OF OVERALL SURVIVAL BENEFIT IN RECURRENT GLIOBLASTOMA TREATED WITH IMMUNE CHECKPOINT INHIBITORS Neuro-Oncology. 23: vi139-vi139. DOI: 10.1093/neuonc/noab196.544  0.054
2015 Subbiah V, Murthy R, Hong D, Prins R, Hosing C, Brown R, Mary M, Naing A, Fu S, Conley A, Kaur I, Hendricks K, Kolli D, Noffsinger L, Bosch M. Safety, feasibility and functionality of activated autologous dendritic cells for intratumoral injection in solid tumors: a Phase I clinical trial Journal For Immunotherapy of Cancer. 3: P199. DOI: 10.1186/2051-1426-3-S2-P199  0.053
2019 Lee A, Pan Y, Mochizuki A, Galvez M, Chow F, Nathanson D, Wang A, Everson R, Liau L, Xing Y, Prins R. IMMU-02. NEOANTIGENS ARISING FROM ALTERNATIVE SPLICING EVENTS MAY BE TARGETED BY TUMOR INFILTRATING LYMPHOCYTES IN GLIOBLASTOMAS Neuro-Oncology. 21: vi118-vi119. DOI: 10.1093/Neuonc/Noz175.496  0.053
2018 Prins R, Mochizuki A, Orpilla J, Lee A, Davidson T, Gaffey S, Sanders C, Rytlewski J, Ellingson B, Li G, Yong W, Clarke J, Arrillaga-Romany I, Colman H, Reardon D, et al. ATIM-12. NEOADJUVANT ANTI-PD-1 IMMUNOTHERAPY PROMOTES INTRATUMORAL AND SYSTEMIC IMMUNE RESPONSES IN RECURRENT GLIOBLASTOMA: AN IVY CONSORTIUM TRIAL Neuro-Oncology. 20: vi3-vi3. DOI: 10.1093/Neuonc/Noy148.007  0.053
2020 Antonios JP, Everson RG, Mochizuki A, Khattab S, Soto H, Romiyo P, Sun MZ, Moughon D, Billingslea-Yoon E, Odesa S, Li G, Kawaguchi E, Salazar A, Yong W, Schlossman J, ... ... Prins RM, et al. Abstract PR13: Adjuvant TLR-3 administration enhances proinflammatory immune responses and is associated with extended survival in glioblastoma patients treated with dendritic cell vaccination Cancer Immunology Research. 8. DOI: 10.1158/2326-6074.Tumimm19-Pr13  0.053
2017 Lee A, Davidson T, Galvez M, Nathanson D, Wang A, Liau L, Prins R. IMMU-20. CHARACTERIZING THE IMMUNE LANDSCAPE OF PD-1/PD-L1 IN BRAIN TUMOR IMMUNE CELL POPULATION USING CyTOF MASS CyTOMETRY Neuro-Oncology. 19: vi116-vi116. DOI: 10.1093/Neuonc/Nox168.478  0.053
2020 Bayley N, Tse C, Zhu H, Yan W, Gosa L, Baufeld L, Ta L, Prins R, Yong W, Cloughesy T, Liau L, Graeber T, Nathanson D. TAMI-48. ENGRAFTMENT PHENOTYPES IN PRECLINICAL MODEL SYSTEMS REVEAL A FUNCTIONAL SUBGROUP OF PATIENT TUMORS DEPENDENT ON THE BRAIN TUMOR MICROENVIRONMENT FOR GROWTH Neuro-Oncology. 22: ii223-ii223. DOI: 10.1093/neuonc/noaa215.935  0.053
2002 Graf MR, Prins RM, Hawkins WT, Merchant RE. Irradiated tumor cell vaccine for treatment of an established glioma. I. Successful treatment with combined radiotherapy and cellular vaccination. Cancer Immunology, Immunotherapy : Cii. 51: 179-89. PMID 12012105 DOI: 10.1007/s00262-002-0269-3  0.053
2012 Prins RG, Brug J, van Empelen P, Oenema A. Effectiveness of YouRAction, an intervention to promote adolescent physical activity using personal and environmental feedback: A cluster RCT Plos One. 7. PMID 22403695 DOI: 10.1371/journal.pone.0032682  0.052
2011 Prins RG, Ball K, Timperio A, Salmon J, Oenema A, Brug J, Crawford D. Associations between availability of facilities within three different neighbourhood buffer sizes and objectively assessed physical activity in adolescents. Health & Place. 17: 1228-34. PMID 21889390 DOI: 10.1016/j.healthplace.2011.07.012  0.052
2012 Lazovic J, Soto H, Piccioni D, Lou JR, Li S, Mirsadraei L, Yong W, Prins R, Liau LM, Ellingson BM, Cloughesy TF, Lai A, Pope WB. Detection of 2-hydroxyglutaric acid in vivo by proton magnetic resonance spectroscopy in U87 glioma cells overexpressing isocitrate dehydrogenase-1 mutation. Neuro-Oncology. 14: 1465-72. PMID 23090985 DOI: 10.1093/Neuonc/Nos258  0.052
2015 Pelargos P, Qin Y, Voth B, Thill K, Chung L, Prins R, Liau L, Ung N, Hojat S, Yong W, Gordon L, Wadehra M, Yang I. MPTH-27A LARGE-SCALE UCLA GLIOMA TISSUE MICROARRAY IDENTIFIES EMP2 AS A NOVEL BIOMARKER FOR GBM THAT CORRELATES WITH OVERALL PROGNOSIS Neuro-Oncology. 17: v144.2-v144. DOI: 10.1093/Neuonc/Nov222.27  0.052
2019 Liu F, Cox CD, Chowdhury R, Dovek L, Nguyen H, Li T, Li S, Ozer B, Chou A, Nguyen N, Wei B, Antonios J, Soto H, Kornblum H, Liau L, ... Prins R, et al. SPINT2 is hypermethylated in both IDH1 mutated and wild-type glioblastomas, and exerts tumor suppression via reduction of c-Met activation. Journal of Neuro-Oncology. PMID 30838489 DOI: 10.1007/S11060-019-03126-X  0.052
2007 Kimura T, Koya RC, Anselmi L, Sternini C, Wang HJ, Comin-Anduix B, Prins RM, Faure-Kumar E, Rozengurt N, Cui Y, Kasahara N, Stripecke R. Lentiviral vectors with CMV or MHCII promoters administered in vivo: immune reactivity versus persistence of expression. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 1390-9. PMID 17505480 DOI: 10.1038/Sj.Mt.6300180  0.052
2008 Prins RM, Shu CJ, Radu CG, Vo DD, Khan-Farooqi H, Soto H, Yang MY, Lin MS, Shelly S, Witte ON, Ribas A, Liau LM. Anti-tumor activity and trafficking of self, tumor-specific T cells against tumors located in the brain. Cancer Immunology, Immunotherapy : Cii. 57: 1279-89. PMID 18253732 DOI: 10.1007/S00262-008-0461-1  0.052
2009 Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, Fantin VR, Jang HG, Jin S, Keenan MC, Marks KM, Prins RM, Ward PS, Yen KE, Liau LM, et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature. 462: 739-44. PMID 19935646 DOI: 10.1038/Nature08617  0.051
2008 Moldenhauer J, Pretorius ZA, Moerschbacher BM, Prins R, Van Der Westhuizen AJ. Histopathology and PR-protein markers provide insight into adult plant resistance to stripe rust of wheat. Molecular Plant Pathology. 9: 137-45. PMID 18705847 DOI: 10.1111/j.1364-3703.2007.00449.x  0.051
2007 Liau LM, Prins RM, Odesa SK, Yang MY, Lin MS, Khan-Farooqi H, Soto H, Lai A, Bosch M, Boynton A, Cloughesy TF. Dendritic cell vaccination in combination with TLR-7 agonist, imiquimod, following radio-chemotherapy for newly diagnosed glioblastoma Journal of Clinical Oncology. 25: 2021-2021. DOI: 10.1200/jco.2007.25.18_suppl.2021  0.051
2004 Prins RM, Incardona F, Lau R, Lee P, Claus S, Zhang W, Black KL, Wheeler CJ. Characterization of defective CD4-CD8- T cells in murine tumors generated independent of antigen specificity. Journal of Immunology (Baltimore, Md. : 1950). 172: 1602-11. PMID 14734741  0.051
2014 Lisiero DN, Soto H, Everson RG, Liau LM, Prins RM. The histone deacetylase inhibitor, LBH589, promotes the systemic cytokine and effector responses of adoptively transferred CD8+ T cells. Journal For Immunotherapy of Cancer. 2: 8. PMID 25054063 DOI: 10.1186/2051-1426-2-8  0.05
2012 Yang I, Choy W, Kim W, Alakandy L, Voth B, Prins RM, Liau LM. Active immunotherapy in glioma: Focus on cell-based approaches Drugs of the Future. 37: 19-31. DOI: 10.1358/dof.2012.37.1.1703571  0.05
2014 Everson RG, Jin RM, Wang X, Safaee M, Scharnweber R, Lisiero DN, Soto H, Liau LM, Prins RM. Cytokine responsiveness of CD8(+) T cells is a reproducible biomarker for the clinical efficacy of dendritic cell vaccination in glioblastoma patients. Journal For Immunotherapy of Cancer. 2: 10. PMID 24883189 DOI: 10.1186/2051-1426-2-10  0.05
2021 Sun L, Lai T, Prins RM. Is there a role for neoadjuvant anti-PD-1 therapies in glioma? Current Opinion in Neurology. PMID 34608074 DOI: 10.1097/WCO.0000000000000992  0.05
2014 Prins RG, Pierik F, Etman A, Sterkenburg RP, Kamphuis CB, van Lenthe FJ. How many walking and cycling trips made by elderly are beyond commonly used buffer sizes: results from a GPS study. Health & Place. 27: 127-33. PMID 24603010 DOI: 10.1016/j.healthplace.2014.01.012  0.049
2011 Konkankit VV, Kim W, Koya RC, Eskin A, Dam MA, Nelson S, Ribas A, Liau LM, Prins RM. Decitabine immunosensitizes human gliomas to NY-ESO-1 specific T lymphocyte targeting through the Fas/Fas ligand pathway. Journal of Translational Medicine. 9: 192. PMID 22060015 DOI: 10.1186/1479-5876-9-192  0.049
2012 Hickey MJ, Malone CC, Erickson KE, Gomez GG, Young EL, Liau LM, Prins RM, Kruse CA. Implementing preclinical study findings to protocol design: translational studies with alloreactive CTL for gliomas. American Journal of Translational Research. 4: 114-26. PMID 22347526  0.049
2018 Orpilla J, Mochizuki A, Reynoso J, Akkad N, Lee A, Davidson T, Liau L, Cloughesy T, Prins R. ATIM-25. NEOADJUVANT PD-1 ANTIBODY BLOCKADE IS ASSOCIATED WITH FOCAL UPREGULATION OF PD-L1 AND CD8 T CELL INFILTRATE IN RECURRENT GLIOBLASTOMA Neuro-Oncology. 20: vi6-vi6. DOI: 10.1093/Neuonc/Noy148.020  0.049
2014 Etman A, Kamphuis CBM, Prins RG, Burdorf A, Pierik FH, van Lenthe FJ. Characteristics of residential areas and transportational walking among frail and non-frail Dutch elderly: Does the size of the area matter? International Journal of Health Geographics. 13. PMID 24588848 DOI: 10.1186/1476-072X-13-7  0.049
2016 Hsu M, Sedighim S, Wang T, Antonios JP, Everson RG, Tucker AM, Du L, Emerson R, Yusko E, Sanders C, Robins H, Yong WH, Davidson TB, Li G, Liau LM, ... Prins RM, et al. TCR sequencing can identify and track glioma-infiltrating T cells after DC vaccination. Cancer Immunology Research. PMID 26968205 DOI: 10.1158/2326-6066.Cir-15-0240  0.049
2020 Morrow D, Nathanson D, Cloughesy T, Prins R, Bayley N, Liau L, Bensinger S, Williams K. CBIO-05. LIPID METABOLIC REPROGRAMMING SENSITIZES A MOLECULARLY-DEFINED SUBSET OF GLIOBLASTOMAS TO FERROPTOSIS Neuro-Oncology. 22: ii16-ii16. DOI: 10.1093/neuonc/noaa215.065  0.049
2006 Prins RM, Craft N, Bruhn KW, Khan-Farooqi H, Koya RC, Stripecke R, Miller JF, Liau LM. The TLR-7 agonist, imiquimod, enhances dendritic cell survival and promotes tumor antigen-specific T cell priming: relation to central nervous system antitumor immunity. Journal of Immunology (Baltimore, Md. : 1950). 176: 157-64. PMID 16365406 DOI: 10.4049/Jimmunol.176.1.157  0.048
2021 Morrow D, Minami J, Bayley N, Williams K, Prins R, Liau L, Cloughesy T, Bensinger S, Nathanson D. CBIO-03. A COMPREHENSIVE CHARACTERIZATION OF THE GBM LIPIDOME REVEALS A MOLECULARLY-DEFINED SUB-GROUP WITH HEIGHTENED SENSITIVITY TO FERROPTOSIS Neuro-Oncology. 23: vi27-vi27. DOI: 10.1093/neuonc/noab196.104  0.048
2014 Erickson KL, Malone CC, Hickey MJ, Owens GC, Kato Y, Prins RM, Kasahara N, Kruse CA. Abstract 1660: Retroviral replicating vector transduced alloresponsive T lymphocytes retain mobility and cytotoxic functionalities Cancer Research. 74: 1660-1660. DOI: 10.1158/1538-7445.Am2014-1660  0.048
2014 Subbiah V, Kayaleh O, Murthy R, Hong D, Fu S, Naing A, Conley A, Hosing C, Kaur I, Prins R, Meric-Bernstam F, Bosch M. Activated autologous dendritic cells injected intratumorally are able to overcome local and systemic immune suppression imposed by the tumor and its microenvironment Journal For Immunotherapy of Cancer. 2. DOI: 10.1186/2051-1426-2-S3-P61  0.048
2019 Sun M, Orpilla J, Contreras E, Treger J, Molaie D, Tsang J, Antonios J, Wang A, Liau L, Prins R, Everson R. IMMU-50. SYSTEMIC ADOPTIVE TRANSFER IMMUNOTHERAPY WITH TCR-TRANSDUCED T-CELLS TARGETING NY-ESO-1 FOR MENINGIOMA Neuro-Oncology. 21: vi129-vi130. DOI: 10.1093/Neuonc/Noz175.542  0.048
2015 Foley L, Panter J, Heinen E, Prins R, Ogilvie D. Changes in active commuting and changes in physical activity in adults: A cohort study International Journal of Behavioral Nutrition and Physical Activity. 12. DOI: 10.1186/s12966-015-0323-0  0.048
2017 Antonios JP, Soto H, Everson RG, Moughon DL, Wang AC, Orpilla J, Radu C, Ellingson BM, Lee JT, Cloughesy T, Phelps ME, Czernin J, Liau LM, Prins RM. Detection of immune responses after immunotherapy in glioblastoma using PET and MRI. Proceedings of the National Academy of Sciences of the United States of America. PMID 28874539 DOI: 10.1073/Pnas.1706689114  0.048
2020 Chavez C, Everson R, Orpilla J, Lee A, Khattab S, Antonios J, Salazar A, Cloughesy T, Liau L, Sun L, Hugo W, Prins R. CTIM-18. DENDRITIC CELL VACCINATION IN CONJUNCTION WITH ADJUVANT TLR-3 AGONIST ADMINISTRATION ENHANCES PRO-INFLAMMATORY IMMUNE RESPONSES AND IS ASSOCIATED WITH EXTENDED SURVIVAL IN MALIGNANT GLIOMA PATIENTS Neuro-Oncology. 22: ii36-ii37. DOI: 10.1093/neuonc/noaa215.152  0.048
2009 Prins RG, Oenema A, van der Horst K, Brug J. Objective and perceived availability of physical activity opportunities: differences in associations with physical activity behavior among urban adolescents. The International Journal of Behavioral Nutrition and Physical Activity. 6: 70. PMID 19832969 DOI: 10.1186/1479-5868-6-70  0.048
2015 Sedighim S, Hsu M, Antonios J, Emerson R, Yusko E, Sanders C, Davidson T, Liau L, Prins R. IMCT-11NEXT GENERATION T CELL RECEPTOR SEQUENCING CAN IDENTIFY, QUANTIFY, AND TRACK TUMOR-SPECIFIC T CELL POPULATIONS BEFORE AND AFTER DENDRITIC CELL VACCINATION IN GLIOBLASTOMA MULTIFORME PATIENTS Neuro-Oncology. 17: v109.4-v110. DOI: 10.1093/Neuonc/Nov218.11  0.047
2013 Prins RM, Wang X, Soto H, Young E, Lisiero DN, Fong B, Everson R, Yong WH, Lai A, Li G, Cloughesy TF, Liau LM. Comparison of glioma-associated antigen peptide-loaded versus autologous tumor lysate-loaded dendritic cell vaccination in malignant glioma patients. Journal of Immunotherapy (Hagerstown, Md. : 1997). 36: 152-7. PMID 23377664 DOI: 10.1097/Cji.0B013E3182811Ae4  0.047
2012 Fong B, Jin R, Wang X, Safaee M, Lisiero DN, Yang I, Li G, Liau LM, Prins RM. Monitoring of regulatory T cell frequencies and expression of CTLA-4 on T cells, before and after DC vaccination, can predict survival in GBM patients. Plos One. 7: e32614. PMID 22485134 DOI: 10.1371/Journal.Pone.0032614  0.047
2006 Prins RM, Vo DD, Khan-Farooqi H, Yang MY, Soto H, Economou JS, Liau LM, Ribas A. NK and CD4 cells collaborate to protect against melanoma tumor formation in the brain. Journal of Immunology (Baltimore, Md. : 1950). 177: 8448-55. PMID 17142742  0.046
2012 Yang J, Nagasawa DT, Spasic M, Amolis M, Choy W, Garcia HM, Prins RM, Liau LM, Yang I. Endogenous vaults and bioengineered vault nanoparticles for treatment of glioblastomas: implications for future targeted therapies. Neurosurgery Clinics of North America. 23: 451-8. PMID 22748657 DOI: 10.1016/j.nec.2012.04.012  0.046
2011 Guo D, Reinitz F, Youssef M, Hong C, Nathanson D, Akhavan D, Kuga D, Amzajerdi AN, Soto H, Zhu S, Babic I, Tanaka K, Dang J, Iwanami A, Gini B, ... ... Prins RM, et al. An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway. Cancer Discovery. 1: 442-56. PMID 22059152 DOI: 10.1158/2159-8290.Cd-11-0102  0.046
2017 Qin Y, Takahashi M, Sheets K, Soto H, Tsui J, Pelargos P, Antonios JP, Kasahara N, Yang I, Prins RM, Braun J, Gordon LK, Wadehra M. Epithelial membrane protein-2 (EMP2) promotes angiogenesis in glioblastoma multiforme. Journal of Neuro-Oncology. PMID 28597184 DOI: 10.1007/S11060-017-2507-8  0.046
2015 Antonios J, Soto H, Orpilla J, Shin N, Everson R, Liau L, Prins R. Adjuvant inhibition of iAPC function in the tumor microenvironment promotes therapeutic immunity in the setting of vaccination-induced T cell anti-tumor response Journal For Immunotherapy of Cancer. 3. DOI: 10.1186/2051-1426-3-S2-P393  0.045
2014 Kruse C, Liau L, Prins R, Antonios J, Ha E, Kasahara N, Soto H, Yang I. Chronic inflammation drives glioma growth: cellular and molecular factors responsible for an immunosuppressive microenvironment Neuroimmunology and Neuroinflammation. 1: 66. DOI: 10.4103/2347-8659.139717  0.045
2001 Prins RM, Graf MR, Merchant RE. Cytotoxic T cells infiltrating a glioma express an aberrant phenotype that is associated with decreased function and apoptosis. Cancer Immunology, Immunotherapy : Cii. 50: 285-92. PMID 11570581 DOI: 10.1007/s002620100202  0.045
2020 Dunn GP, Cloughesy TF, Maus MV, Prins RM, Reardon DA, Sonabend AM. Emerging Immunotherapies for Malignant Glioma: From Immunogenomics to Cell Therapy. Neuro-Oncology. PMID 32615600 DOI: 10.1093/neuonc/noaa154  0.045
2021 Lai T, Treger J, Rao J, Prins R, Everson R. IMMU-30. IDENTIFICATION OF COORDINATELY REGULATED IMMUNO-MODULATORY GENES USING SINGLE-CELL RNA SEQUENCING OF DECITABINE TREATED GLIOMA CELLS Neuro-Oncology. 23: vi99-vi99. DOI: 10.1093/neuonc/noab196.389  0.045
2015 Okada H, Weller M, Huang R, Finocchiaro G, Gilbert MR, Wick W, Ellingson BM, Hashimoto N, Pollack IF, Brandes AA, Franceschi E, Herold-Mende C, Nayak L, Panigrahy A, Pope WB, ... Prins R, et al. Immunotherapy response assessment in neuro-oncology: a report of the RANO working group. The Lancet. Oncology. 16: e534-42. PMID 26545842 DOI: 10.1016/S1470-2045(15)00088-1  0.045
2005 Khan-Farooqi HR, Prins RM, Liau LM. Tumor immunology, immunomics and targeted immunotherapy for central nervous system malignancies. Neurological Research. 27: 692-702. PMID 16197806 DOI: 10.1179/016164105X49490  0.045
2015 Fu X, Chin RM, Vergnes L, Hwang H, Deng G, Xing Y, Pai MY, Li S, Ta L, Fazlollahi F, Chen C, Prins RM, Teitell MA, Nathanson DA, Lai A, et al. 2-Hydroxyglutarate Inhibits ATP Synthase and mTOR Signaling. Cell Metabolism. PMID 26190651 DOI: 10.1016/J.Cmet.2015.06.009  0.044
2006 Yang MY, Zetler PM, Prins RM, Khan-Farooqi H, Liau LM. Immunotherapy for patients with malignant glioma: from theoretical principles to clinical applications. Expert Review of Neurotherapeutics. 6: 1481-94. PMID 17078788 DOI: 10.1586/14737175.6.10.1481  0.044
2015 Erickson KL, Hickey MJ, Kato Y, Malone CC, Owens GC, Prins RM, Liau LM, Kasahara N, Kruse CA. Radial mobility and cytotoxic function of retroviral replicating vector transduced, non-adherent alloresponsive T lymphocytes. Journal of Visualized Experiments : Jove. PMID 25741775 DOI: 10.3791/52416  0.044
2002 Prins RM, Scott GP, Merchant RE, Graf MR. Irradiated tumor cell vaccine for treatment of an established glioma. II. Expansion of myeloid suppressor cells that promote tumor progression. Cancer Immunology, Immunotherapy : Cii. 51: 190-9. PMID 12012106 DOI: 10.1007/s00262-002-0270-x  0.044
2021 Arrieta VA, Chen AX, Kane JR, Kang SJ, Kassab C, Dmello C, Zhao J, Burdett KB, Upadhyayula PS, Lee-Chang C, Shilati J, Jaishankar D, Chen L, Gould A, Zhang D, ... ... Prins R, et al. ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma Nature Cancer. 2: 1372-1386. DOI: 10.1038/s43018-021-00260-2  0.043
2019 Mochizuki A, Lee A, Garcia A, Prins R, Wang A, Davidson T. Immu-22. Single-Cell Characterization Of Intratumoral And Systemic Immune Populations In Pediatric And Adult Brain Tumors Reveals Differences In Subpopulation Composition, Activation And Memory Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz036.141  0.043
2006 Prins RM, Bruhn KW, Craft N, Lin JW, Kim CH, Odesa SK, Miller JF, Liau LM. Central nervous system tumor immunity generated by a recombinant listeria monocytogenes vaccine targeting tyrosinase related protein-2 and real-time imaging of intracranial tumor burden. Neurosurgery. 58: 169-78; discussion 1. PMID 16385341 DOI: 10.1227/01.Neu.0000192367.29047.64  0.043
1999 Liau LM, Black KL, Prins RM, Sykes SN, DiPatre PL, Cloughesy TF, Becker DP, Bronstein JM. Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens. Journal of Neurosurgery. 90: 1115-24. PMID 10350260 DOI: 10.3171/jns.1999.90.6.1115  0.043
2017 Chung LK, Pelargos PE, Chan AM, Demos JV, Lagman C, Sheppard JP, Nguyen T, Chang YL, Hojat SA, Prins RM, Liau LM, Nghiemphu L, Lai A, Cloughesy TF, Yong WH, et al. Tissue microarray analysis for epithelial membrane protein-2 as a novel biomarker for gliomas. Brain Tumor Pathology. PMID 28887715 DOI: 10.1007/S10014-017-0300-1  0.043
2021 Ott M, Prins RM, Heimberger AB. The immune landscape of common CNS malignancies: implications for immunotherapy. Nature Reviews. Clinical Oncology. PMID 34117475 DOI: 10.1038/s41571-021-00518-9  0.043
2007 Prins RJ, Kasarda MEF, Prins SCB. A system identification technique using bias current perturbation for determining the effective rotor origin of active magnetic bearings Journal of Vibration and Acoustics, Transactions of the Asme. 129: 317-322. DOI: 10.1115/1.2724976  0.043
2012 Yang I, Jian Y, Garcia H, Choy W, Nagasawa DT, Spasic M, Trang A, Soto H, Ericcson K, Lisiero D, Hickey M, Kruse C, Prins RM, Rome L, Liau LM. 198 An Antigen Vault Nanoparticle Vaccine Can Effectively Stimulate Dendritic Cells and Activate a Specific T cell Immune Response. Neurosurgery. 71: E576-E577. PMID 28175807 DOI: 10.1227/01.neu.0000417788.76126.66  0.043
2019 Chakhoyan A, Yao J, Leu K, Pope WB, Salamon N, Yong W, Lai A, Nghiemphu PL, Everson RG, Prins RM, Liau LM, Nathanson DA, Cloughesy TF, Ellingson BM. Validation of vessel size imaging (VSI) in high-grade human gliomas using magnetic resonance imaging, image-guided biopsies, and quantitative immunohistochemistry. Scientific Reports. 9: 2846. PMID 30808879 DOI: 10.1038/S41598-018-37564-W  0.042
2003 Prins RM, Graf MR, Merchant RE, Black KL, Wheeler CJ. Thymic function and output of recent thymic emigrant T cells during intracranial glioma progression. Journal of Neuro-Oncology. 64: 45-54. PMID 12952285 DOI: 10.1007/BF02700019  0.042
2011 Lisiero DN, Soto H, Liau LM, Prins RM. Enhanced sensitivity to IL-2 signaling regulates the clinical responsiveness of IL-12-primed CD8(+) T cells in a melanoma model. Journal of Immunology (Baltimore, Md. : 1950). 186: 5068-77. PMID 21430221 DOI: 10.4049/Jimmunol.1003317  0.042
2009 Shu CJ, Radu CG, Shelly SM, Vo DD, Prins R, Ribas A, Phelps ME, Witte ON. Quantitative PET reporter gene imaging of CD8+ T cells specific for a melanoma-expressed self-antigen. International Immunology. 21: 155-65. PMID 19106231 DOI: 10.1093/Intimm/Dxn133  0.042
2013 Lasky JL, Panosyan EH, Plant A, Davidson T, Yong WH, Prins RM, Liau LM, Moore TB. Autologous tumor lysate-pulsed dendritic cell immunotherapy for pediatric patients with newly diagnosed or recurrent high-grade gliomas. Anticancer Research. 33: 2047-56. PMID 23645755  0.041
2015 Everson RG, Antonios JP, Lisiero DN, Soto H, Scharnweber R, Garrett MC, Yong WH, Li N, Li G, Kruse CA, Liau LM, Prins RM. Efficacy of systemic adoptive transfer immunotherapy targeting NY-ESO-1 for glioblastoma. Neuro-Oncology. PMID 26330563 DOI: 10.1093/Neuonc/Nov153  0.041
2011 Prins RM, Soto H, Konkankit V, Odesa SK, Eskin A, Yong WH, Nelson SF, Liau LM. Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 1603-15. PMID 21135147 DOI: 10.1158/1078-0432.Ccr-10-2563  0.04
2017 Mochizuki AY, Frost I, Mastrodimos M, Plant AS, Wang AC, Moore TB, Prins RM, Weiss PS, Jonas SJ. Precision Medicine in Pediatric Neurooncology: A Review. Acs Chemical Neuroscience. PMID 29199818 DOI: 10.1021/Acschemneuro.7B00388  0.04
2020 Chuntova P, Chow F, Watchmaker P, Galvez M, Heimberger AB, Newell EW, Diaz A, DePinho RA, Li MO, Wherry EJ, Mitchell D, Terabe M, Wainwright DA, Berzofsky JA, Herold-Mende C, ... ... Prins RM, et al. Unique challenges for glioblastoma immunotherapy - Discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Neuro-Oncology. PMID 33367885 DOI: 10.1093/neuonc/noaa277  0.04
2019 Yao J, Chakhoyan A, Nathanson DA, Yong WH, Salamon N, Raymond C, Mareninov S, Lai A, Nghiemphu PL, Prins RM, Pope WB, Everson RG, Liau LM, Cloughesy TF, Ellingson BM. Metabolic characterization of human IDH mutant and wild type gliomas using simultaneous pH- and oxygen-sensitive molecular MRI. Neuro-Oncology. PMID 31066901 DOI: 10.1093/Neuonc/Noz078  0.04
2015 Prins RG, van Lenthe FJ. The hour-to-hour influence of weather conditions on walking and cycling among Dutch older adults. Age and Ageing. 44: 886-90. PMID 26259948 DOI: 10.1093/ageing/afv103  0.04
2015 Erdem Ö, Prins RG, Voorham TA, van Lenthe FJ, Burdorf A. Structural neighbourhood conditions, social cohesion and psychological distress in the Netherlands. European Journal of Public Health. PMID 26142403 DOI: 10.1093/eurpub/ckv120  0.04
2012 Agenbag GM, Pretorius ZA, Boyd LA, Bender CM, Prins R. Identification of adult plant resistance to stripe rust in the wheat cultivar Cappelle-Desprez Theoretical and Applied Genetics. 125: 109-120. PMID 22350093 DOI: 10.1007/s00122-012-1819-5  0.039
2004 Yang I, Kremen TJ, Giovannone AJ, Paik E, Odesa SK, Prins RM, Liau LM. Modulation of major histocompatibility complex Class I molecules and major histocompatibility complex-bound immunogenic peptides induced by interferon-alpha and interferon-gamma treatment of human glioblastoma multiforme. Journal of Neurosurgery. 100: 310-9. PMID 15086239 DOI: 10.3171/jns.2004.100.2.0310  0.039
2003 Prins RM, Odesa SK, Liau LM. Immunotherapeutic targeting of shared melanoma-associated antigens in a murine glioma model. Cancer Research. 63: 8487-91. PMID 14679014  0.039
2018 Liau LM, Ashkan K, Tran DD, Campian JL, Trusheim JE, Cobbs CS, Heth JA, Salacz M, Taylor S, D'Andre SD, Iwamoto FM, Dropcho EJ, Moshel YA, Walter KA, Pillainayagam CP, ... ... Prins RM, et al. First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma. Journal of Translational Medicine. 16: 142. PMID 29843811 DOI: 10.1186/S12967-018-1507-6  0.037
2007 Kasarda ME, Marshall J, Prins R. Active magnetic bearing based force measurement using the multi-point technique Mechanics Research Communications. 34: 44-53. DOI: 10.1016/j.mechrescom.2006.06.003  0.037
2008 Bere E, van der Horst K, Oenema A, Prins R, Brug J. Socio-demographic factors as correlates of active commuting to school in Rotterdam, the Netherlands. Preventive Medicine. 47: 412-6. PMID 18657568 DOI: 10.1016/j.ypmed.2008.06.019  0.036
2004 Prins RM, Liau LM. Cellular immunity and immunotherapy of brain tumors. Frontiers in Bioscience : a Journal and Virtual Library. 9: 3124-36. PMID 15353342  0.036
2015 Antonios J, Soto H, Orpilla J, Shin N, Everson R, Liau L, Prins R. TMIC-04THERAPEUTIC ANTI-GLIOMA IMMUNITY IS DEPENDENT ON VACCINATION-INDUCED T CELL RESPONSES AND INHIBITION OF iAPC FUNCTION IN THE TUMOR MICROENVIRONMENT Neuro-Oncology. 17: v214.8-v215. DOI: 10.1093/Neuonc/Nov236.04  0.036
2018 Lee A, Mochizuki A, Ishihara M, Garcia A, Nathanson D, Wang A, Everson R, Liau L, Prins R. IMMU-21. MULTIDIMENSIONAL CHARACTERIZATION OF IMMUNE CELL POPULATIONS IN THE GLIOMA TUMOR MICROENVIRONMENT REVEALS A DOMINANT PROPORTION OF CELLS DERIVED FROM THE MYELO-MONOCYTIC LINEAGE Neuro-Oncology. 20: vi125-vi125. DOI: 10.1093/Neuonc/Noy148.524  0.036
2005 Craft N, Bruhn KW, Nguyen BD, Prins R, Liau LM, Collisson EA, De A, Kolodney MS, Gambhir SS, Miller JF. Bioluminescent imaging of melanoma in live mice. The Journal of Investigative Dermatology. 125: 159-65. PMID 15982316 DOI: 10.1111/J.0022-202X.2005.23759.X  0.036
2010 Prins RG, Van Empelen P, Te Velde SJ, Timperio A, Van Lenthe FJ, Tak NI, Crawford D, Brug J, Oenema A. Availability of sports facilities as moderator of the intention-sports participation relationship among adolescents Health Education Research. 25: 489-497. PMID 20382675 DOI: 10.1093/her/cyq024  0.035
2012 Prins RC, Rademacher BL, Mongoue-Tchokote S, Alumkal JJ, Graff JN, Eilers KM, Beer TM. C-reactive protein as an adverse prognostic marker for men with castration-resistant prostate cancer (CRPC): Confirmatory results Urologic Oncology: Seminars and Original Investigations. 30: 33-37. PMID 20207556 DOI: 10.1016/j.urolonc.2009.11.012  0.035
2000 Yu JS, Wheeler CJ, Zeltzer PM, Nacis-Finger D, Lee PK, Prins R, Yong W, Thompson RC, Riedinger M, Zhang W, Black KL. 721 Vaccination of Recurrent Malignant Glioma Patients with Tumor-lysate Pulsed Dendritic Cells Elicits a Potent T-cell Anti-tumor Response Neurosurgery. 47: 505-505. DOI: 10.1097/00006123-200008000-00069  0.035
2014 Li S, Chowdhury R, Liu F, Chou AP, Li T, Mody RR, Lou JJ, Chen W, Reiss J, Soto H, Prins R, Liau LM, Mischel PS, Nghiemphu PL, Yong WH, et al. Tumor-suppressive miR148a is silenced by CpG island hypermethylation in IDH1-mutant gliomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 5808-22. PMID 25224277 DOI: 10.1158/1078-0432.Ccr-14-0234  0.035
2008 Prins RM, Odesa S, Soto H, Yong WH, Lai A, Bosch M, Boynton A, Cloughesy TF, Liau LM. Autologous tumor-lysate pulsed dendritic cell vaccination, together with the TLR-7 agonist 5% imiquimod, and serum pro- inflammatory cytokine levels in glioblastoma patients. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 11021. PMID 27947675 DOI: 10.1200/Jco.2008.26.15_Suppl.11021  0.034
2020 Ladomersky E, Zhai L, Lauing KL, Bell A, Xu J, Kocherginsky M, Zhang B, Wu JD, Podojil JR, Platanias LC, Mochizuki AY, Prins RM, Kumthekar P, Raizer J, Dixit K, et al. Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with Glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32546647 DOI: 10.1158/1078-0432.Ccr-19-3874  0.034
2016 Moughon D, Everson R, Odesa S, Soto H, Billingslea-Yoon E, Sedighim S, Orpilla J, Lin J, Prins R, Liau L. ATIM-32. PHASE IIA CLINICAL TRIAL EVALUATING DENDRITIC CELL VACCINE FOR THE TREATMENT OF LOW-GRADE GLIOMAS Neuro-Oncology. 18: vi25-vi25. DOI: 10.1093/Neuonc/Now212.097  0.034
2016 Antonios J, Soto H, Everson R, Orpilla J, Shin N, Moughon D, Sedighim S, Treger J, Odesa S, Tucker A, Yong W, Cloughesy T, Prins R, Liau L. TMIC-16. TUMOR-INFILTRATING MYELOID CELLS MEDIATE ADAPTIVE IMMUNE RESISTANCE IN GLIOBLASTOMA Neuro-Oncology. 18: vi203-vi203. DOI: 10.1093/Neuonc/Now212.856  0.034
2010 Prins RM, Soto H, Konkankit V, Yong WH, Nelson SF, Liau LM. Abstract 4749: Genetic signature of malignant glioma is associated with responsiveness to autologous tumor lysate-pulsed dendritic cell vaccination + TLR agonists Cancer Research. 70: 4749-4749. DOI: 10.1158/1538-7445.Am10-4749  0.034
2016 Everson R, Shin N, Antonios J, Soto H, Tucker A, Zaretsky J, Orpilla J, Rathe S, Popescu F, Largaespada D, Liau L, Prins R. IMST-56. TUMOR LYSATE-PULSED DC VACCINATION INDUCES NEOANTIGEN-SPECIFIC T CELL RESPONSES Neuro-Oncology. 18: vi99-vi99. DOI: 10.1093/Neuonc/Now212.412  0.033
2014 Moertel CL, Xia J, LaRue R, Waldron NN, Andersen BM, Prins RM, Okada H, Donson AM, Foreman NK, Hunt MA, Pennell CA, Olin MR. CD200 in CNS tumor-induced immunosuppression: the role for CD200 pathway blockade in targeted immunotherapy. Journal For Immunotherapy of Cancer. 2: 46. PMID 25598973 DOI: 10.1186/S40425-014-0046-9  0.033
2010 Prins RG, Van Empelen P, Beenackers MA, Brug J, Oenema A. Systematic development of the YouRAction program, a computer-tailored physical activity promotion intervention for Dutch adolescents, targeting personal motivations and environmental opportunities Bmc Public Health. 10. PMID 20701782 DOI: 10.1186/1471-2458-10-474  0.033
2019 Owens GC, Garcia AJ, Mochizuki AY, Chang JW, Reyes SD, Salamon N, Prins RM, Mathern GW, Fallah A. Evidence for Innate and Adaptive Immune Responses in a Cohort of Intractable Pediatric Epilepsy Surgery Patients. Frontiers in Immunology. 10: 121. PMID 30761153 DOI: 10.3389/fimmu.2019.00121  0.032
2001 Yu JS, Wheeler CJ, Zeltzer PM, Ying H, Finger DN, Lee PK, Yong WH, Incardona F, Thompson RC, Riedinger MS, Zhang W, Prins RM, Black KL. Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration. Cancer Research. 61: 842-7. PMID 11221866  0.03
2001 Graf MR, Prins RM, Merchant RE. IL-6 secretion by a rat T9 glioma clone induces a neutrophil-dependent antitumor response with resultant cellular, antiglioma immunity. Journal of Immunology (Baltimore, Md. : 1950). 166: 121-9. PMID 11123284  0.03
2013 Goren AD, Prins RD, Dauer LT, Quinn B, Al-Najjar A, Faber RD, Patchell G, Branets I, Colosi DC. Effect of leaded glasses and thyroid shielding on cone beam CT radiation dose in an adult female phantom. Dento Maxillo Facial Radiology. 42: 20120260. PMID 23412460 DOI: 10.1259/Dmfr.20120260  0.03
2014 Shih J, Rahman M, Luong QT, Lomeli SH, Riss J, Prins RM, Gure AO, Zeng G. Dominant B-cell epitopes from cancer/stem cell antigen SOX2 recognized by serum samples from cancer patients. American Journal of Clinical and Experimental Immunology. 3: 84-90. PMID 25143868  0.03
2015 Jansen FM, Prins RG, Etman A, van der Ploeg HP, de Vries SI, van Lenthe FJ, Pierik FH. Physical activity in non-frail and frail older adults. Plos One. 10: e0123168. PMID 25910249 DOI: 10.1371/journal.pone.0123168  0.029
2009 Prins R, Verhoef PC, Franses PH. The impact of adoption timing on new service usage and early disadoption International Journal of Research in Marketing. 26: 304-313. DOI: 10.1016/J.Ijresmar.2009.07.002  0.029
2004 Ramburan VP, Pretorius ZA, Louw JH, Boyd LA, Smith PH, Boshoff WH, Prins R. A genetic analysis of adult plant resistance to stripe rust in the wheat cultivar Kariega. Tag. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik. 108: 1426-33. PMID 14963651 DOI: 10.1007/s00122-003-1567-7  0.027
2013 Flink IJ, Prins RG, Mackenbach JJ, Jaddoe VW, Hofman A, Verhulst FC, Tiemeier H, Raat H. Neighborhood ethnic diversity and behavioral and emotional problems in 3 year olds: results from the Generation R Study. Plos One. 8: e70070. PMID 23967068 DOI: 10.1371/Journal.Pone.0070070  0.027
2011 Prins R, Dauer LT, Colosi DC, Quinn B, Kleiman NJ, Bohle GC, Holohan B, Al-Najjar A, Fernandez T, Bonvento M, Faber RD, Ching H, Goren AD. Significant reduction in dental cone beam computed tomography (CBCT) eye dose through the use of leaded glasses. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 112: 502-7. PMID 21802322 DOI: 10.1016/J.Tripleo.2011.04.041  0.026
2018 Garrett M, Sperry J, Braas D, Yan W, Le TM, Mottahedeh J, Ludwig K, Eskin A, Qin Y, Levy R, Breunig JJ, Pajonk F, Graeber TG, Radu CG, Christofk H, ... Prins RM, et al. Metabolic characterization of isocitrate dehydrogenase (IDH) mutant and IDH wildtype gliomaspheres uncovers cell type-specific vulnerabilities. Cancer & Metabolism. 6: 4. PMID 29692895 DOI: 10.1186/S40170-018-0177-4  0.026
2016 Antonios J, Soto H, Everson R, Orpilla J, Shin N, Nathanson D, Harris R, Sadeghi S, Ellingson B, Liau L, Prins R. IMST-28. NON-INVASIVE IMMUNE MONITORING FOLLOWING DC VACCINATION EFFECTIVELY DELINEATES IMMUNE RESPONSES IN GLIOBLASTOMA Neuro-Oncology. 18: vi92-vi92. DOI: 10.1093/Neuonc/Now212.384  0.025
2003 Graf MR, Prins RM, Poulsen GA, Merchant RE. Contrasting effects of interleukin-2 secretion by rat glioma cells contingent upon anatomical location: accelerated tumorigenesis in the central nervous system and complete rejection in the periphery. Journal of Neuroimmunology. 140: 49-60. PMID 12864971 DOI: 10.1016/S0165-5728(03)00167-X  0.025
2000 Black KL, Wheeler CJ, Zeltzer PM, Nacis-Finger D, Lee PK, Prins R, Yong WH, Thompson RC, Riedinger M, Zhang W, Yu JS. 722 Dendritic Cell Vaccination of Patients with Malignant Glioma Elicits Systemic and Intracranial T-cell Response Neurosurgery. 47: 506-506. DOI: 10.1097/00006123-200008000-00070  0.025
2018 Liau LM, Ashkan K, Tran DD, Campian JL, Trusheim JE, Cobbs CS, Heth JA, Salacz M, Taylor S, D'Andre SD, Iwamoto FM, Dropcho EJ, Moshel YA, Walter KA, Pillainayagam CP, ... ... Prins RM, et al. Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma. Journal of Translational Medicine. 16: 179. PMID 29958537 DOI: 10.1186/S12967-018-1552-1  0.025
2004 Prins RM, Liau LM. Cancer Immunotherapy at the Crossroads: How Tumors Evade Immunity and What Can Be Done Neuro-Oncology. 6: 265-266. DOI: 10.1215/S1152851703200077  0.025
2011 Prins RD, Thornton RH, Schmidtlein CR, Quinn B, Ching H, Dauer LT. Estimating radiation effective doses from whole body computed tomography scans based on U.S. soldier patient height and weight. Bmc Medical Imaging. 11: 20. PMID 22004072 DOI: 10.1186/1471-2342-11-20  0.025
2013 Prins RG, Kamphuis CBM, Van Empelen P, Beenackers MA, Brug J, Mackenbach JP, Oenema A. Explaining socio-demographic differences in disengagement from sports in adolescence European Journal of Public Health. 23: 811-816. PMID 23302764 DOI: 10.1093/eurpub/cks188  0.024
2018 Bethel J, Aliche J, Orpilla J, Soto H, Everson R, Davidson T, Wang A, Liau L, Prins R. IMMU-37. VEMURAFENIB ENHANCES THE CYTOTOXICITY OF NY-ESO-1 TCR ENGINEERED T-CELLS FOR BRAF MUTANT BRAIN TUMORS Neuro-Oncology. 20: vi129-vi129. DOI: 10.1093/Neuonc/Noy148.540  0.024
1996 Prins RM, Garcia L, Tidball JG. MODIFIED MUSCLE USE RESULTS IN A SHIFT IN THE DISTRIBUTION AND INCREASE IN THE CONCENTRATION OF MATRIX METALLOPROTEASE-2 842 Medicine &Amp Science in Sports &Amp Exercise. 28: 141. DOI: 10.1097/00005768-199605001-00840  0.022
2010 Lehmensiek A, Bester-van der Merwe AE, Sutherland MW, Platz G, Kriel WM, Potgieter GF, Prins R. Population structure of South African and Australian Pyrenophora teres isolates Plant Pathology. 59: 504-515. DOI: 10.1111/j.1365-3059.2009.02231.x  0.022
2012 Van Der Gulden J, De Zwart B, Prins R. The position of the occupational physician Part. 1 Employer and employee viewpoints | De positie van de bedrijfsarts: Deel 1. Visie van werkgevers en werknemers Tijdschrift Voor Bedrijfs- En Verzekeringsgeneeskunde. 20: 299-305. DOI: 10.1007/s12498-012-0144-x  0.021
2014 Prins RG, Pierik F, Etman A, Sterkenburg RP, Kamphuis CBM, van Lenthe FJ. How many walking and cycling trips made by elderly are beyond commonly used buffer sizes: Results from a GPS study Health and Place. 27: 127-133. DOI: 10.1016/j.healthplace.2014.01.012  0.02
2014 Beenackers MA, Kamphuis CB, Prins RG, Mackenbach JP, Burdorf A, van Lenthe FJ. Urban form and psychosocial factors: do they interact for leisure-time walking? Medicine and Science in Sports and Exercise. 46: 293-301. PMID 24051658 DOI: 10.1249/MSS.0000000000000017  0.02
2017 Soto H, Antonios J, Everson R, Moughon D, Wang A, Orpilla J, Radu C, Ellingson B, Lee J, Cloughesy T, Phelps M, Czernin J, Liau L, Prins R. NIMG-36. DELINEATION OF IMMUNE RESPONSES AFTER IMMUNOTHERAPY IN GLIOBLASTOMA USING PET AND MRI Neuro-Oncology. 19: vi149-vi150. DOI: 10.1093/Neuonc/Nox168.611  0.02
2012 Hickey MJ, Malone CC, Erickson KE, Gomez GG, Young EL, Liau LM, Prins RM, Kruse CA. Implementing preclinical study findings to protocol design: Translational studies with alloreactive CTL for gliomas American Journal of Translational Research. 4: 114-126.  0.019
2013 Al Najjar A, Colosi D, Dauer LT, Prins R, Patchell G, Branets I, Goren AD, Faber RD. Comparison of adult and child radiation equivalent doses from 2 dental cone-beam computed tomography units. American Journal of Orthodontics and Dentofacial Orthopedics : Official Publication of the American Association of Orthodontists, Its Constituent Societies, and the American Board of Orthodontics. 143: 784-92. PMID 23726328 DOI: 10.1016/J.Ajodo.2013.01.013  0.019
2007 Van Rooij GJ, Al RS, Brezinsek S, Goedheer WJ, De Groot B, Kleyn AW, Koppers WR, Van Der Meiden HJ, Prins RP, Schram DC, Shumack AE, Vijvers WAJ, Westerhout J, Lopes Cardozo NJ. Carbon erosion experiments in the ITER relevant flux regime 34th Eps Conference On Plasma Physics 2007, Eps 2007 - Europhysics Conference Abstracts. 31: 375-378.  0.019
2008 Prins RM, Cloughesy TF, Liau LM. Cytomegalovirus immunity after vaccination with autologous glioblastoma lysate. The New England Journal of Medicine. 359: 539-41. PMID 18669440 DOI: 10.1056/NEJMc0804818  0.018
2012 Prins RG, Mohnen SM, van Lenthe FJ, Brug J, Oenema A. Are neighbourhood social capital and availability of sports facilities related to sports participation among Dutch adolescents? International Journal of Behavioral Nutrition and Physical Activity. 9. PMID 22849512 DOI: 10.1186/1479-5868-9-90  0.018
2018 Antonios J, Everson R, Soto H, Khattab S, Bethel J, Sun M, Mochizuki A, Lee A, Odesa S, Billingslea-Yoon E, Moughon D, Wang A, Cloughesy T, Prins R, Liau L. ATIM-39. IMPROVED SURVIVAL NOTED IN GLIOBLASTOMA PATIENTS TREATED WITH ADJUVANT TLR-3 AGONIST IN SETTING OF AUTOLOGOUS LYSATE-PULSED DC VACCINATION Neuro-Oncology. 20: vi10-vi10. DOI: 10.1093/Neuonc/Noy148.034  0.018
2011 Prins R, Pretorius ZA, Bender CM, Lehmensiek A. QTL mapping of stripe, leaf and stem rust resistance genes in a Kariega × Avocet S doubled haploid wheat population Molecular Breeding. 27: 259-270. DOI: 10.1007/s11032-010-9428-y  0.018
2012 Pretorius ZA, Jin Y, Bender CM, Herselman L, Prins R. Seedling resistance to stem rust race Ug99 and marker analysis for Sr2, Sr24 and Sr31 in South African wheat cultivars and lines Euphytica. 186: 15-23. DOI: 10.1007/s10681-011-0476-0  0.018
2014 Beenackers MA, Kamphuis CBM, Prins RG, Mackenbach JP, Burdorf A, Van Lenthe FJ. Urban form and psychosocial factors: Do they interact for leisure-time walking? Medicine and Science in Sports and Exercise. 46: 293-301. DOI: 10.1249/MSS.0000000000000017  0.018
2015 Gipson KG, Prins RJ. Materials and mechanics: A multidisciplinary course incorporating experiential, project/problem-based, and work-integrated learning approaches for undergraduates Handbook of Research On Recent Developments in Materials Science and Corrosion Engineering Education. 230-252. DOI: 10.4018/978-1-4666-8183-5.ch012  0.017
2014 Burger P, Vermeulen A, Halleen F, Koopman T, Van Heerden CJ, Prins R. Table grape breeding at the ARC Infruitec-Nietvoorbij, South Africa; Its impact on the SA industry and latest developments Acta Horticulturae. 1046: 245-250.  0.017
2009 Wuyts S, Verhoef PC, Prins R. Partner selection in B2B information service markets International Journal of Research in Marketing. 26: 41-51. DOI: 10.1016/j.ijresmar.2008.07.008  0.017
2014 Agenbag GM, Pretorius ZA, Boyd LA, Bender CM, MacCormack R, Prins R. High-resolution mapping and new marker development for adult plant stripe rust resistance QTL in the wheat cultivar Kariega Molecular Breeding. 34: 2005-2020. DOI: 10.1007/s11032-014-0158-4  0.016
2015 Prins R, Sones BA, Schlich D. Application-based learning, a nuclear experimental laboratory in a field environment Asee Annual Conference and Exposition, Conference Proceedings. 122.  0.016
2016 Everson R, Tucker A, Garrett M, Marcus L, Harris R, Prins R, Ellingson B, Liau L. SURG-21. CASE-MATCHED STUDY OF EFFECT OF INTRA-OPERATIVE MRI ON EXTENT OF RESECTION AND CLINICAL OUTCOME IN GLIOMA PATIENTS UNDERGOING SURGICAL RESECTION Neuro-Oncology. 18: vi195-vi195. DOI: 10.1093/Neuonc/Now212.822  0.016
2014 Classen CF, William D, Linnebacher M, Farhod A, Kedr W, Elsabe B, Fadel S, Van Gool S, De Vleeschouwer S, Koks C, Garg A, Ehrhardt M, Riva M, De Vleeschouwer S, Agostinis P, ... ... Prins R, et al. HIGH GRADE GLIOMAS AND DIPG Neuro-Oncology. 16: i40-i59. DOI: 10.1093/Neuonc/Nou071  0.015
2015 Visch V, Mulder I, Bos W, Prins R. The travelling rose: A persuasive game to stimulate walking behaviour of older persons in low SES neighbourhoods Gamification: Concepts, Methodologies, Tools, and Applications. 3: 1296-1311. DOI: 10.4018/978-1-4666-8200-9.ch065  0.015
2014 Al Najjar A, Colosi D, Dauer LT, Prins R, Patchell G, Branets I, Goren AD, Faber RD. Authors' response. American Journal of Orthodontics and Dentofacial Orthopedics : Official Publication of the American Association of Orthodontists, Its Constituent Societies, and the American Board of Orthodontics. 145: 125-6. PMID 24485719 DOI: 10.1016/j.ajodo.2013.11.007  0.015
2012 Van Der Gulden J, De Zwart B, Prins R. The position of the occupational physician. Part 2. Viewpoints of the professionals themselves | De positie van de bedrijfsarts: Deel 2. Visie van de beroepsgroep Tijdschrift Voor Bedrijfs- En Verzekeringsgeneeskunde. 20: 350-356. DOI: 10.1007/s12498-012-0166-4  0.015
2011 Bere E, Oenema A, Prins RG, Seiler S, Brug J. Longitudinal associations between cycling to school and weight status International Journal of Pediatric Obesity. 6: 182-187. PMID 21644849 DOI: 10.3109/17477166.2011.583656  0.014
2018 Antonios JP, Soto H, Everson RG, Wang AC, Bethel J, Radu C, Ellingson B, Phelps M, Cloughesy TF, Prins RM, Liau LM. 214 Noninvasive Monitoring of Immunotherapeutic Responses in Glioblastoma Using Novel Imaging Techniques Neurosurgery. 65: 120-120. DOI: 10.1093/Neuros/Nyy303.214  0.014
2014 Fu X, Chin RM, Vergnes L, Hwang H, Deng G, Xing Y, Pai MY, Li S, Ta L, Fazlollahi F, Chen C, Prins RM, Teitell MA, Nathanson DA, Lai A, et al. 2-Hydroxyglutarate Inhibits ATP Synthase and mTOR Signaling Cell Metabolism. DOI: 10.1016/j.cmet.2015.06.009  0.013
2016 Lee AH, Prins RM. New applications for deep sequencing of the T cell receptor repertoire in cancer patients Translational Cancer Research. 5: S842-S843. DOI: 10.21037/TCR.2016.10.10  0.013
2015 Gipson KG, Prins RJ. Integrative multidisciplinary materials & mechanicsteam project Asee Annual Conference and Exposition, Conference Proceedings. 122.  0.012
2007 Kim W, Prins RM, Liau LM. EPIGENETIC MODIFICATIONS OF CANCER ANTIGEN EXPRESSION IN GLIOMAS. Journal of Investigative Medicine. 55: S121. DOI: 10.1097/00042871-200701010-00284  0.012
2014 Terefe TG, Visser B, Herselman L, Prins R, Negussie T, Kolmer JA, Pretorius ZA. Diversity in Puccinia triticina detected on wheat from 2008 to 2010 and the impact of new races on South African wheat germplasm European Journal of Plant Pathology. 139: 95-105. DOI: 10.1007/s10658-013-0368-3  0.012
2008 Moldenhauer J, Pretorius ZA, Moerschbacher BM, Prins R, Van Der Westhuizen AJ. Histopathology and PR-protein markers provide insight into adult plant resistance to stripe rust of wheat (Molecular Plant Pathology (2008) 9, (137-146)) Molecular Plant Pathology. 9: 561. DOI: 10.1111/j.1364-3703.2008.00490.x  0.012
2014 van Heerden CJ, Burger P, Vermeulen A, Prins R. Detection of downy and powdery mildew resistance QTL in a 'Regent' × 'RedGlobe' population Euphytica. DOI: 10.1007/s10681-014-1167-4  0.012
2014 Prins RG, Beenackers MA, Boog MC, Van Lenthe FJ, Brug J, Oenema A. Neighbourhood social capital as a moderator between individual cognitions and sports behaviour among Dutch adolescents Social Science and Medicine. 105: 9-15. PMID 24606792 DOI: 10.1016/j.socscimed.2013.12.031  0.012
2010 Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, Fantin VR, Jang HG, Jin S, Keenan MC, Marks KM, Prins RM, Ward PS, Yen KE, Liau LM, et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature. 465: 966. PMID 20559394 DOI: 10.1038/nature09132  0.012
2015 Pretorius ZA, Visser B, Terefe T, Herselman L, Prins R, Soko T, Siwale J, Mutari B, Selinga TI, Hodson DP. Races of Puccinia triticina detected on wheat in Zimbabwe, Zambia and Malawi and regional germplasm responses Australasian Plant Pathology. 44: 217-224. DOI: 10.1007/s13313-014-0339-y  0.012
2008 Prins R, Kandemir M. Time-constrained optimization of multi-auv cooperative mine detection Oceans 2008. DOI: 10.1109/OCEANS.2008.5151971  0.011
2012 Prins RP. Unintended consequences: The story of health care in the United States American Journal of Obstetrics and Gynecology. 206: 509-512. PMID 22631863 DOI: 10.1016/j.ajog.2012.01.003  0.011
2010 Van De Brug E, Van Bergen M, Van Griethuysen DE, De Boom W, Prins R, Kuijpers P. Optimal integrated combination of foundation concept and installation method European Wind Energy Conference and Exhibition 2010, Ewec 2010. 5: 3947-3948.  0.011
2006 Prins R. Mental health problems and disability pensions: Trends and measures in a cross-national perspective Journal of Public Health. 14: 371-375. DOI: 10.1007/s10389-006-0073-1  0.01
2015 Dwyier D, Gulledge B, Hays W, Prins R. Electric commuter bicycle 2015 Systems and Information Engineering Design Symposium, Sieds 2015. 240-245. DOI: 10.1109/SIEDS.2015.7116982  0.01
2015 Bastiaanse R, Prins RS. Aphasia The Cambridge Handbook of Communication Disorders. 224-246. DOI: 10.1017/CBO9781139108683.016  0.01
2015 Pretorius ZA, Prins R, Malaker PK, Barma NCD, Hakim MA, Thapa D, Bansal U, Cisar GL, Park RF. Assessing the vulnerability of wheat germplasm from Bangladesh and Nepal to Ug99 stem rust Phytoparasitica. 43: 637-645. DOI: 10.1007/s12600-015-0487-9  0.01
2015 Wild JM, Nagel RL, Prins RJ. A student-developed rotational mechanics laboratory exercise to link engineering design and science Asee Annual Conference and Exposition, Conference Proceedings. 122.  0.01
2013 Campian J, Gladstone D, Ambady P, Ye X, King K, Borrello I, Petrik S, Golightly M, Holdhoff M, Grossman S, Bhardwaj R, Chakravadhanula M, Ozols V, Georges J, Carlson E, ... ... Prins R, ... ... Prins R, et al. IMMUNOTHERAPY/BIOLOGICAL THERAPIES Neuro-Oncology. 15: iii68-iii74. DOI: 10.1093/Neuonc/Not178  0.01
2013 Aaberg-Jessen C, Fogh L, Halle B, Jensen V, Brunner N, Kristensen BW, Abe T, Momii Y, Watanabe J, Morisaki I, Natsume A, Wakabayashi T, Fujiki M, Aldaz B, Fabius AWM, ... ... Prins R, et al. EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY Neuro-Oncology. 15: iii37-iii61. DOI: 10.1093/Neuonc/Not176  0.01
2013 Grant T, Prins R. Identifying tools and technologies for professional offensive cyber operations 8th International Conference On Information Warfare and Security, Iciw 2013. 80-89.  0.01
2012 Prins R, Cachet L, Ponsaers P, Hughes G. Fragmentation and interconnection in public safety governance in the Netherlands, Belgium and England Innovation and the Public Sector. 17: 19-43. DOI: 10.3233/978-1-60750-998-1-19  0.01
2012 Pollack IF, Jakacki RI, Butterfield L, Okada H, Chiba Y, Hashimoto N, Kagawa N, Kinoshita M, Kijima N, Hirayama R, Oji Y, Tsuboi A, Oka Y, Sugiyama H, Yoshimine T, ... ... Prins RM, et al. CLIN-IMMUNOTHERAPY/BIOLOGIC THERAPIES Neuro-Oncology. 14: vi43-vi49. DOI: 10.1093/Neuonc/Nos224  0.01
2012 Fujita M, Zhang R, Nakata S, Kuzushima K, Wainwright DA, Balyasnikova IV, Auffinger B, Ahmed AU, Han Y, Lesniak MS, Knight A, Arnouk H, Gillespie GY, Britt W, Su Y, ... ... Prins RM, et al. LAB-IMMUNOLOGY RESEARCH Neuro-Oncology. 14: vi38-vi42. DOI: 10.1093/Neuonc/Nos223  0.01
2010 Prins R, Pappas E. Exploring the value of design and build experiences for undergraduate engineering students Asee Annual Conference and Exposition, Conference Proceedings.  0.01
2009 Pierrakos O, Kander R, Pappas E, Prins R. An innovative engineering curriculum at James Madison University: Transcending disciplinary boundaries through innovative problem based learning practices Asme International Mechanical Engineering Congress and Exposition, Proceedings. 9: 189-195. DOI: 10.1115/IMECE2008-68015  0.01
2009 Prins R. A team-based design competition for freshmen engineering students that emphasizes sustainable design Asee Annual Conference and Exposition, Conference Proceedings.  0.01
2009 Prins R, Van Heerden CJ, Burger AL, Burger P, Smit WA. DNA fingerprinting of table grape cultivars Acta Horticulturae. 827: 269-274.  0.01
2008 Prins R, Kander R, Moore T, Pappas E, Pierrakos O. Special Session - Engineering for a sustainable world: How do we incorporate sustainability in undergraduate engineering education? Proceedings - Frontiers in Education Conference, Fie. S2J1-S2J2. DOI: 10.1109/FIE.2008.4720521  0.01
2008 Prins R, Pierrakos O, Pappas E, Kander R. Work in progress - A freshman engineering course designed to convey the essence of the engineering program at James Madison University Proceedings - Frontiers in Education Conference, Fie. S1D1-S1D2. DOI: 10.1109/FIE.2008.4720519  0.01
2007 Prins R, Verhoef PC. Marketing communication drivers of adoption timing of a new e-service among existing customers Journal of Marketing. 71: 169-183. DOI: 10.1509/jmkg.71.2.169  0.01
2007 Pretorius ZA, Pakendorf KW, Marais GF, Prins R, Komen JS. Challenges for sustainable cereal rust control in South Africa Australian Journal of Agricultural Research. 58: 593-601. DOI: 10.1071/AR06144  0.01
2007 Pretorius ZA, Pienaar L, Prins R. Greenhouse and field assessment of adult plant resistance in wheat to Puccinia striiformis f. sp. tritici Australasian Plant Pathology. 36: 552-559. DOI: 10.1071/AP07058  0.01
2007 Costin C, Anita V, Al RS, De Groot B, Goedheer W, Kleyn AW, Koppers WR, Lopes Cardozo NJ, Van Der Meiden HJ, Van De Peppel RJE, Prins RP, Van Rooij GJ, Shumack AE, Solomon ML, Vijvers WAJ, et al. On the power balance at the end plate of the plasma column in Pilot-PSI 34th Eps Conference On Plasma Physics 2007, Eps 2007 - Europhysics Conference Abstracts. 31: 1978-1981.  0.01
Hide low-probability matches.